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ABSTRACT
IDENTIFICATION AND CHARACTERIZATION OF PHOTORHABDUS
TEMPERATA MUTANTS ALTERED IN HEMOLYSIS AND VIRULENCE
by
Christine A. Chapman
University of New Hampshire, December, 2011
Photorhabdus temperata is an invertebrate pathogen and nematode symbiont that
is commonly used as a biological control agent in the management of commercial crop
pests. The focus of this study was to investigate the poorly understood molecular
elements involved in the expression of hemolysis and virulence in this bacterium. A
10,000 transposant library was screened using a blood agar plate assay to identify
mutants altered in hemolytic activity. A total of 74 mutants displaying defective, delayed,
or early hemolysis were identified and subsequently tested for altered virulence in the
Greater Waxmoth, Galleria mellonella, using an in vitro mortality assay. Ten mutants
delayed in pathogenesis were identified. Molecular analysis identified the sites of
transposon insertion in 16 hemolysis mutants, eight of which also displayed delayed
virulence. A critical finding of this study was the involvement of RNases in the
regulation of hemolysis and pathogenesis.

IX

CHAPTER I

INTRODUCTION

ENTOMOPATHOGENIC NEMATODES AND AGRICULTURE

In the United States alone, the agricultural industry spends $10 billion on
pesticide use annually (Pimentel and Greiner, 1997) with a significant portion of this cost
designated to the control of commercial crop insects. Still, 13% of all potential crops in
the U.S. are destroyed due to insect damage (Pimentel, 1997). The necessity to control
economically detrimental pests has resulted in the widespread use of potent chemical
insecticides. Although historically effective, recent data highlight marked disadvantages
as well as the decreasing efficacy of such chemicals. Concerns with chemical pesticide
use include harm to nontarget organisms via contamination of soil and groundwater,
biomagnification, and elimination of beneficial competitor insects (Chattopadhyay et al.,
2004). Veterinary use of broad spectrum pesticides risks contaminating products in the
meat and dairy industries as well (Georgis et al., 2006). These chemicals tend to degrade
slowly or not at all, resulting in environmental persistence and toxicity to humans
(Chattopadhyay et al., 2004). Furthermore, the recent emergence of pesticide-resistant
insects has necessitated the use of higher dosages and newly-developed chemicals.
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Entomopathogenic nematodes have been in use as biological control agents in the
United States since the 1980's (Georgis et al., 2006) and are growing in popularity in
response to the call for reduced chemical pesticide use. Entomopathogenic nematodes are
naturally soil-dwelling roundworms that infect larval-stage insects. The two genera of
nematode used as biocontrol agents are Heterorhabditis and Steinernema, which form
symbiotic relationships with the bacteria Photorhabdus and Xenorhabdus, respectively
(Boemare et al., 1996). The exploitation of this natural symbiosis for pest control in
agriculture offers numerous benefits over conventional chemical insecticide use.
Entomopathogenic nematodes have a broad host range, capable of infecting over 200
species of insects (Georgis et al., 2006), many of which are commercial crop pests.
Additionally, the symbiotic bacterial species are a much safer alternative for animals and
humans alike as they do not target vertebrate species (Boemare et a l , 1996). The risk for
persistence and contamination is eliminated because nematodes do not accumulate in the
environment. Because these species are actively predacious, they offer a high efficacy for
insect control. The nematodes can be dispersed via traditional mechanisms used for
pesticides, such as ground and aerial sprayers and irrigation systems (Chattopadhyay et
al., 2004; Georgis, 1990), making the application of this type of biocontrol agent just as
feasible as chemical insecticides. Finally, the use of organic biological control agent
eliminates the risk of insects developing pesticide resistance.

PHOTORHABDUS

TEMPERATA AND RELATED SPECIES

The genus Photorhabdus is comprised of three closely related but unique species,
Photorhabdus temperata, Photorhabdus luminescens, and Photorhabdus
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asymbiotica,

which are further divided into subspecies based on phenotypic characteristics and 16S
rDNA diversity (Fischer-Le Saux et al., 1999; Waterfield et al., 2009). All members of
the Photorhabdus genus, however, are defined by several core characteristics. The
Photorhabdus bacterium is a gram-negative, rod-shaped, facultatively-anaerobic, motile
member of the Enterobacteriaceae and is the only known terrestrial bioluminescent
bacterium (Gerrard et al., 2011; Waterfield et al., 2009). Photorhabdus lives in a
mutualistic symbiotic relationship with heterorhabditid nematodes and is also pathogenic
to insects (Waterfield et al., 2009).
A peculiar aspect of the Photorhabdus life cycle is the transition from the typical
wild-type form to a secondary form that exhibits a number of phenotypic changes. This
rare phenotypic switch is referred to as phase variation and is believed to occur under
conditions of prolonged laboratory cultivation (Akhurst, 1980). These two forms differ in
their ability to absorb dyes on differential culture media including MacConkey, NBTA,
and EMB agar. Additionally, the secondary variant has decreased or defective activity of
extracellular enzymes, antimicrobial activity, and bioluminescence (Lanois et al., 2011).
Photorhabdus is closely related to a sister species, Xenorhabdus. In 1993, Boemare et
al. proposed the transfer of Photorhabdus to its own genus based on DNA relatedness. In
2003, Duchaud et al. released the complete genome sequence of P. luminescens strain
TT01. P. asymbiotica strain ATCC43949 has also been released (Wilkinson et al., 2009).
P. asymbiotica is the clinical strain, which has been implicated in a few cases of human
infection. The presence of a plasmid allows this species to grow at 37°C, while the others
cannot (Wilkinson et al., 2009). Currently, the P. temperata NCI9 genome is being
completed (Tisa, unpublished).
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PHOTORHABDUS AND HETERORHABDITIS: PARTNERS IN CRIME

P. temperata has a multiphasic life cycle requiring both pathogenesis of insects
and a beneficial symbiosis with the nematode Heterorhabditis bacteriophora (Figure 1).
Together, these mutualist entomopathogens infect a wide variety of insects where
Photorhabdus assumes the role of a highly virulent pathogen. The pathogenic nature of
Photorhabdus further supports the growth and development of Heterorhabditis within the
insect host, thereby linking the two in a continuous cycle of symbiosis and pathogenesis.
Heterorhabditis bacteriophora is a soil-dwelling entomopathogenic nematode
which carries Photorhabdus within its intestine (Burnell and Stock, 2000). During its
infective juvenile (IJ) stage, H. bacteriophora is free-living in the environment and is
actively predacious against a variety of larval insects. The IJs infect suitable larval hosts
via natural openings including the mouth, anus, and spiracles, or by penetrating the
insect's cuticle directly. Once inside the insect's hemocoel, the nematodes regurgitate the
bacterial cells which immediately begin working to break down the host's tissues (Ciche
and Ensign, 2003). Although the nematodes themselves may inflict structural damage on
the insect contributing to mortality, the action of potent exotoxins secreted by
Photorhabdus ultimately destroys the insect (Burnell and Stock, 2000).
Photorhabdus secretes a variety of toxins that kill the host in roughly 48 hours
(Brillard et al., 2002; Burnell and Stock, 2000). Photorhabdus also releases exoenzymes,
such as proteases, lipases, lipopolysaccharides, and cytolysins, within the hemocoel. The
enzymes produced by the bacterial cells continue to degrade the internal environment of
the insect, creating a milieu of nutrients in which the IJs mature into adult hermaphrodites
and begin several generations of reproduction within the cadaver (Goodrich-Blair and
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Clarke, 2007). This reproductive cycle lasts for two to three weeks before a new
generation of IJs release a signal which triggers the uptake of Photorhabdus cells into the
nematode intestine. The symbiotic pair then exits the cadaver and disperses into the
environment where the IJs begin searching for new prey.

5

A)
> --""*"

„--•"

J>~^

E)

Infective
Juvenile (IJ)

^
\

B)

\Z
C)
D)
^
Adult ^*Hermaphrodite

1. The life cycle of the Photorhabdus-Heterorhabditis association. A)
Photorhabdus cells are carried symbiotically within the gut of the infective juvenile (IJ)
stage of the nematode Heterorhabditis bacteriophora. B) IJs seek out and infect larval
insect hosts in the soil. C) Once inside, Photorhabdus are released from the nematodes
and kill the host within 48 hours and D) the IJs mature into adult hermaphroditic
nematodes. E) The nematodes cycle through several generations of reproduction before
taking the bacterial symbionts into their gut and exiting the cadaver.
FIGURE
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VIRULENCE MECHANISMS

Much like higher eukaryotic organisms, insects possess a myriad of molecular
tactics for warding off infectious organisms. The insect immune system has two primary
mechanisms of defense: humoral and cellular (Eleftherianos et al., 2010). Humoral
immunity utilizes molecules involved in the detection and clearance of antigens, while
the cellular mechanisms employ hemocytes involved in phagocytosis, foreign body
encapsulation, and nodulation. Evasion of insect immune cells and antimicrobial peptides
is crucial to the success of entomopathogens.
The highly virulent nature of Photorhabdus is compounded by the numerous
toxins employed by this bacterium. Several groups of virulence factors have been
identified as the key players in insect pathogenesis: the toxin complexes (Tcs), the
"makes caterpillars floppy" toxins (Mcf), the Photorhabdus insect related proteins (Pir),
and the Photorhabdus virulence cassettes (PVC) (Rodou et al., 2010).
The toxin complexes consist of four high molecular weight multisubunit
complexes, Tea, Tcb, Tec, and Ted (Rodou et al., 2010). Toxin complex a (Tea) is the
most abundant of these toxins and is highly lethal, exhibiting both oral and injectable
activity (Blackburn et al., 1998; 2005). Tea works on the insect midgut, causing blebbing
of the endothelium and eventual cell lysis (Blackburn et al, 1998), and is highly fatal on
its own, possibly in concentrations as low as 1 part per million (Blackburn et al., 2005).
RTX-like toxins have also been identified in Photorhabdus which resemble those found
in Vibrio cholerae, Serratia marcescens, Erwinia tarda, and Erwinia chrysanthemi
(Rodou et al., 2010). Among those are the metalloprotease PrtA, which may be involved
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in immunosuppresion (ffrench-Constant et al., 2000; Duchaud et al., 2003) and host
bioconversion (Bowen et al., 2003).
There are two Mcf ("makes caterpillars floppy") toxins in Photorhabdus, Mcfl
and Mcf2 (Rodou et al., 2010). These toxins contribute to insect death by inducing
apoptosis of both epithelial and phagocytic cells within the midgut (Dowling et al., 2007).
Infected insects display a characteristic floppy appearance due to this cellular breakdown
which becomes apparent at roughly 12 h post-infection, preceding death. The presence of
these toxins may help enable the bacteria in the infection of different insect species
(Rodou et al., 2010).
The Photorhabdus insect related (Pir) toxins, PirA and PirB, work together to
confer injectable insecticidal activity (ffrench-Constant et al., 2007). PirB shares
sequence similarities with p-leptinotarsin-h, a potent neurotoxin identified in the
Colorado potato beetle hemolymph, as well as the pore-forming domain of Bt Cry toxins.
These Pir toxins have the potential for use as biological control toxins, replacing the
current Bt toxin from Bacillus thuringiensis, for which some insect resistance has
emerged (Ahantarig et al., 2009).
The most recently identified class of Photorhabdus toxins are the Photorhabdus
virulence cassettes (PVCs) whose precise function has yet to be identified. These PVCs
are encoded by multiple copies of genes exhibiting homology to toxin genes in Serratia
entomophila specifically involved in antifeeding (Yang et al., 2006; Rodou et al., 2010).
In Photorhabdus, these gene products have injectable activity that work on hemocytes to
assist in insect killing; however, these products do not possess any antimicrobial activity
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despite structurally resembling bacteriocins, specifically the R-type pyocins (Yang et al.,
2006).

HEMOLYSIN ACTIVITY AND FUNCTION

In addition to the diverse and potent toxins secreted by Photorhabdus, the primary
phase wild type cells produce erythrocyte-lysing cytolysins, termed hemolysins (Brillard
et al., 2001). Hemolysins are extracellular pore-forming or cell-hydrolyzing compounds
secreted by many species of bacteria, and typically function as virulence factors in
vertebrate pathogens (Brillard et al., 2001; Brillard et al., 2002). Although the precise
function of hemolysins in Photorhabdus infectivity is unknown, evidence from other
pathogenic systems may help elucidate their role.
Serratia marcescens is both a vertebrate and invertebrate pathogen that expresses
a two-partner hemolysin secretion system comprised of ShlA and ShlB (Brillard et al.,
2002; Hertle, 2005). In this system, ShlA is the hemolytic protein that is transported and
activated by an outer membrane protein, ShlB. A similarly dependent two-partner
secretion system has been identified in Photorhabdus luminescens, comprised of phlA
and phlB, which contain sequence similarities with the S1. marcescens hemolysin loci shlA
and shlB, respectively (Brillard et al., 2002). Similar products are found in P. temperata
NCI9 as well (Tisa, unpublished). Additionally, the phlA and phlB amino acid sequences
share homologies with hemolysin gene products of Edwardsiella

tarda,

Proteus

mirabilis, and Haemophilus ducreyi, and a putative hemolysin of Yersinia pestis, YhlA
(Brillard et al., 2002).
Hemolytic activity is typically distinguished by the visual observation of clear
halos on blood agar media, indicating erythrocyte lysis. Photorhabdus exhibits a distinct
9

pattern of hemolysis, termed "annular", first observed by Farmer et al. in 1989. Annular
hemolysis is characterized by a thin line of hemolysis several millimeters away from the
bacterial colony's edge, but no hemolysis immediately adjacent to the colony on sheep
blood agar. This pattern, however, is not entirely unique; Bacillus cereus exhibits a
similar "discontinuous hemolytic pattern", caused by the BL hemolysin (Beecher and
Wong, 1994; Brillard et al., 2001). In addition, continued growth of both Photorhabdus
and B. cereus leads to eventual lysis of erythrocytes within the annular ring. Interestingly,
this BL hemolysin functions as a major virulence factor of B. cereus, causing
dermonecrotic vascular permeability (Beecher and Wong, 1994).
Numerous putative hemolysin genes have been identified in all three species of
Photorhabdus. The complete genome sequence of P. luminescens TT01 reveals eight
putative hemolysin- or hemagglutinin-related genes, including the phlBA operon
(Duchaud et al., 2003). Eighteen putative hemolysin genes are present in the P.
asymbiotica genome as well (Wilkinson et al., 2009). The currently unpublished draft
genome sequence of P. temperata NCI9 contains 24 putative genes involved in
hemolysis (Tisa, unpublished; http://rast.nmpdr.org/).
Despite the evidence for numerous hemolysin genes in the Photorhabdus
genomes, the identities and functions of these hemolytic compounds remain elusive. A
study of the master flagellar operon flhDC in Xenorhabdus nematophilus suggested the
presence of at least two types of hemolysin: oney7/zDC-independent hemolysin that gives
rise to annular ring formation and one extracellular /7/zZ)C-dependent hemolysin
potentially involved in cytotoxicity to insect immunocompetent cells (Givaudan and
Lanois, 2000). Additionally, flhDC activity was shown to be involved in, but not required
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for, insect infectivity. This finding indicates that there may be a large array of virulence
factors involved in pathogenesis, but the loss of only a few of these factors may not be
detrimental to pathogenesis.
In 2001, Brillard et al. provide further evidence for the existence of two
hemolysins in X. nematophila which are active at different stages of stationary phase and
independently regulated (Brillard et al., 2001). These hemolysins also have different
cytotoxicity against the two most prevalent types of insect immune cells, granulocytes
and plasmatocytes. A hemolytic compound produced during early stationary phase is
active against sheep erythrocytes and primarily toxic to granulocytes, the phagocytic
immune cells. In contrast, late stationary phase cells produced a hemolysin active against
rabbit erythrocytes and cytotoxic to plasmatocytes, the capsule-forming immune cells
involved in the nodulation of foreign bodies. These two different cytolytic events imply a
putative role of hemolysins in insect immunosuppression during infectivity with
Xenorhabdus.
A study of XhlA offered additional support for the involvement of hemolysins in
Xenorhabdus virulence. Disruption of xhlA in X nematophila resulted in significantly
attenuated virulence to Manduca sexta larvae, although this mutant ultimately remained
lethal (Cowles and Goodrich-Blair, 2005). Further characterization of XhlA confirmed
that this hemolysin is not responsible for the early cytolytic activity described by Brillard
et al. (2001), as XhlA was primarily toxic to plasmatocytes. The absence of XhlA activity
in culture supernatant also implies that this hemolysin remains cell-associated. Together,
these data suggest that XhlA may function in virulence by assisting in immune system
evasion or nutrient acquisition inside the insect.
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Although early discoveries focused on hemolytic activity in Xenorhabdus, a study
on the PhlA hemolysin provided evidence for at least two hemolysins in Photorhabdus as
well (Brillard et al., 2002). An insertional mutation in phlA did not cause any alterations
in hemolytic phenotype when compared to the parental wild type on both horse and sheep
blood agar, indicating the presence of an additional hemolysin with activity on blood agar
media. A liquid hemolysis assay, however, did detect the presence of PhlA hemolytic
activity. Interestingly, this assay did not display any hemolytic activity when performed
with filter-sterilized bacterial supernatant only. Similarly, no hemolytic activity was
detected in Photorhabdus culture supernatant during the prior study on the effect of
hemolysins on insect immunocompetent cells (Brillard et al., 2001). These studies
suggest that coincubation of bacteria and erythrocytes is necessary to identify PhlA
hemolytic activity, and that PhlA may actually be cytotoxic to insect immune cells as
well (Brillard et al., 2002).
Previous research on Photorhabdus and Xenorhabdus indicate a possible role of
hemolysis in virulence; however, hemolysis may also function as an iron-scavenging
mechanism during iron depletion. Primary phase P. luminescens displayed an increase in
hemolytic activity under iron-depleted conditions compared to iron-supplemented
conditions (Brillard et al., 2002), whereas the PhlA null mutant had no hemolysis in
either condition. An injection assay using Spodoptera littoralis, however, showed that
this PhlA mutant remained virulent, indicating that PhlA hemolytic activity is not a
significant determinant of virulence in this organism.
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RESEARCH AIMS AND SIGNIFICANCE

Photorhabdus is a unique biological system because it is both an obligate
symbiont of heterorhabditid nematodes and is highly pathogenic to insects. For this
reason, Photorhabdus makes an excellent model organism for studying the molecular
mechanisms involved in both pathogenesis and symbiosis and the relationship between
these two stages of life. Another fascinating and unusual feature of this bacterium is its
ability to lyse mammalian erythrocytes, a virulence factor typically associated with
vertebrate pathogens (Brillard et al., 2001; Brillard et al., 2002). The absence of red blood
cells in insects drives the central question of this research: What function, if any, do these
hemolysins serve in the pathogenesis of this organism? Previous research, along with
current knowledge of hemolysins in vertebrate pathogens, suggests a possible role in
immunoevasion during insect infectivity (Brillard et al., 2001; Brillard et al., 2002;
Cowles and Goodrich-Blair, 2005; Givaudan and Lanois, 2000). The main objectives of
this study were to investigate the molecular mechanisms of hemolysin expression, to
elucidate the role of hemolysins in Photorhabdus virulence, and to ultimately identify
genes involved in pathogenesis. These objectives are outlined in Figure 2.
Previously, a primary-phase Photorhabdus temperata NCI9 transposant library
with 10,000 clones was constructed (Michaels, 2006) using a mini-Tn5 system previously
described (Ciche et al., 2001). The first aim of this study was to screen this library via a
blood agar plate assay to identify mutants displaying altered hemolytic phenotypes. The
goal of identifying these mutants was to characterize them on the molecular level in order
to understand the genetic elements involved in the expression, regulation, and transport
mechanisms of hemolysins in Photorhabdus.
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The second major focus of this research was to investigate the genes involved in
insect pathogenesis. An in vitro injection assay developed by Clarke and Dowds (1995)
uses Galleria mellonella larvae to study Photorhabdus virulence. Although this
procedure is too labor intensive to perform on the entire transposant library, it is effective
for studying pathogenesis in a smaller group of mutants. Initial screening for hemolysis
allowed for the pathogenic characterization of a subset of the library. Previously, an
investigation of Photorhabdus motility mutants found that the absence of RNase II
activity resulted in attenuated virulence (Rowedder, 2009). This finding offered the first
evidence of RNase involvement in the regulation of pathogenesis. Virulence assays in
this study served two purposes: first, to identify mutants altered in pathogenesis for
further molecular characterization, and second, to investigate the potential role between
hemolytic activity and pathogenesis. Ultimately, the mutants altered in both hemolysis
and virulence identified in this study were the main focus for further genetic and
physiological characterization.
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FIGURE

2. Experimental design for the study of hemolysis and virulence in P. temperata.
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CHAPTER II

MATERIALS AND METHODS

BACTERIAL STRAINS AND GROWTH CONDITIONS

Photorhabdus temperata strain NCI9 (ATCC 29304) was used as the parental
wild type bacterium in all experiments throughout this study. Table 1 lists all of the
strains and plasmids used in this study. Both primary (1°) and secondary (2°) phase
phenotypic variants were used as controls in this study. Parental wild type cultures were
grown in Luria-Bertani (LB) medium [1% Bacto-Tryptone (Difco Laboratories, Sparks,
MD), 0.5% yeast extract, 0.5% NaCl], and mutant cultures were grown in LB
supplemented with kanamycin [25 u.g/ml].
A primary phase P. temperata NC19 mutant library was previously generated via
transposon mutagenesis with the mini-Tn5 vector pUB394 (Michaels, 2006). Mutants
from this library were used throughout this study.
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Table 1. Bacterial strains and plasmids used in this study
Strain or Plasmid
Strains
Escherichia coli
DH5a
TOP 10
Micrococcus luteus
Photorhabdus temperata
NCI9 (ATCC29304) 1°
NC19(ATCC29304)2°
9AF6
10AC11
10AH12
11AD12
12AG7
2H12
5A12
22 A2
24 A4
24G12
26 C4
26 E6
27G12
30 C6
30 F2
32 C5
35 B9
32 E4
34 E2
36 CIO
36 D3
36 D6
37 CI
37 C5
38A10
38 CIO
38D10
38E11
38 G3
40D10
40 E6
40 E7

Function/Characteristics

Source or
Reference

General cloning strain
General cloning strain
Indicator strain

Lab stock
Invitrogen
Lab stock

Primary parental wild type
Secondary variant parental wild type
Early hemolysis; KanR
Defective hemolysis; Kan R
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; Kan R
Defective hemolysis; KanR
Defective hemolysis; KanR
Early hemolysis; Kan R
Defective hemolysis; Kan R
Delayed hemolysis; KanR
Delayed hemolysis; KanR
Early hemolysis; KanR
Delayed hemolysis; KanR
Delayed hemolysis; KanR
Delayed hemolysis; KanR
Early hemolysis; KanR
Delayed hemolysis; Kan R
Delayed hemolysis; KanR
Defective hemolysis; KanR
Early hemolysis; KanR
Delayed hemolysis; KanR
Defective hemolysis; KanR
Delayed hemolysis; Kan R
Delayed hemolysis; Kan R
Early hemolysis; KanR
Defective hemolysis; Kan R
Defective hemolysis; Kan R
Early hemolysis; Kan R
Defective hemolysis; KanR
Delayed hemolysis; KanR
Defective hemolysis; KanR
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Fischer-Le Saux
etal., 1999
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006

Table 1 (cont.)
ain or Plasmid
41 B3
41 D5
46 G6
47 H6
50 C5
51 F9
53 H3
56 H7
59 G4
59 G6
60 A2
61 E8
62 A7
65 B5
65 CIO
65 D5
67 HI
69 Dl
69 H6
71 H4
72C12
72 F9
78 E3
79 B5
79G12
80 A l l
81 C4
81 E2
81 F5
82A12
82B11
82 D2
82H12
83 Al
83 El
84 El
84H11
86 C7
86 G2
89 F5

Function/Characteristics
Defective hemolysis; KanR
Delayed hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Delayed hemolysis; Kan R
Early hemolysis; KanR
Defective hemolysis; KanR
Early hemolysis; Kan R
Delayed hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Delayed hemolysis; KanR
Delayed hemolysis; KanR
Defective hemolysis; KanR
Delayed hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Delayed hemolysis; Kan R
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; Kan R
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Early hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Defective hemolysis; KanR
Early hemolysis; KanR
Delayed hemolysis; KanR
Defective hemolysis; KanR
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Source or
Reference
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006
Michaels, 2006

Table 1 (cont.)
Strain or Plasmid
90 B9
90 E2
Plasmids
pUB384

Function/Characteristics
Defective hemolysis; KanK
Defective hemolysis; KanR
mini-Tn5 delivery vector; KanR, StrR, SpecR
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Source or
Reference
Michaels, 2006
Michaels, 2006

Ciche et al., 2001

HEMOLYSIS ASSAY TO IDENTIFY MUTANTS ALTERED IN HEMOLYTIC ABILITY

The transposon mutant library was screened for hemolysis activity on blood agar
plates (Figure 3). Blood agar medium was composed of T-soy [3% Tryptic Soy Broth
(EM Science, Darmstadt, Germany), 2% Bacto-Agar (Difco Laboratories)] supplemented
with sheep's blood [5%, v:v]. For the screening experiments, blood agar medium was
poured into oversized petri dishes (150x15 mm; Fisher Scientific, Canada). The mutant
library was stored at -80°C in a collection of 96-well microtiter plates as previously
described (Michaels, 2006). Using a 96-well replicator, the -80°C stored transposants
were transferred into 96-well microtiter plates containing fresh LB medium with
kanamycin and incubated overnight at 28°C. The freshly grown overnight culture was
replica plated directly onto the oversized blood agar plates. Two ul of the primary and
secondary phase parental wild type cells were spotted on each plate as controls. Plates
were incubated at 28°C and observed at 24, 48, and 72 h for hemolytic patterns. Criteria
for determining altered hemolytic activity were time-dependent. Putative mutants
displayed early, delayed, or defective hemolysis when compared to the primary parental
wild type which exhibited hemolysis between 19 and 24 h. Preliminary mutants identified
as altered in their hemolytic pattern were purified by isolation streaks and retested at least
3 times. For these cultures, 2 ul of each overnight broth culture including the primary and
secondary wild type controls were spot inoculated onto the surface of blood agar plates
and incubated for 72 h. Hemolytic activity was monitored every 24 h. Confirmed mutants
were purified by streaking on LB agar containing kanamycin. A single colony was
inoculated into LB broth and grown overnight. Cells were suspended in 30% glycerol and
stored at -80°C for further study.
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FIGURE 3. Hemolysis plate assay for the screening and identification of hemolytic
mutants. A) Overnight grown cultures in 96-well plates were spot inoculated onto sheep
blood agar plates by the use of a pin replicator and incubated at 28°C. B) Hemolytic
activity was observed at 24, 48, and 72 h post-incubation. C) Putative hemolytic mutants
were subcultured and 2 ul of each overnight culture was spot inoculated onto blood agar
plates for verification.
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IN VITRO INSECT PATHOGENESIS ASSAY

Insect pathogenesis was assessed by a modified method of Clarke and Dowds
(1995) and used the greater wax moth larvae, Galleria mellonella, (Grubco, Inc.
Hamilton, OH) as the host (Figure 4). Prior to use larvae were stored at room temperature
in wood shavings for up to two weeks. Bacterial cultures were grown in LB broth
overnight at 28°C with agitation and optical density of the culture was measured with a
Shimadzu UV-2401 PC spectrophotometer (Norwell, MA). Cultures were diluted to an
OD60o of 1-0 and subsequently serially diluted. Ten ul of the 10"5 dilution (approximately
100 cells) were injected directly into the hemocoel of 20 larvae. Controls consisted of
primary and secondary parental wild type cells and sterile LB medium (no cells; negative
control). Insect mortality was monitored regularly for 60 h and the lethal time required to
kill half of the larvae (LT50) and all of the larvae (LTioo) was determined. Mutants
displaying LT50 or LT100 that differed by greater than 10 h from the parental wild type
values were considered to have an enhanced (<10 h) or delayed (>10 h) pathogenesis
response. To obtain a viable cell count for each inoculum, 10 ul of the injected dilution
was spread plated onto LB agar containing 10% pyruvate (supplemented with kanamycin
for mutant cultures) and incubated at 28°C overnight. A multiplicity of infection (MOI)
assay was used to confirm that the altered virulence observed in putative pathogenesis
mutants was not dose-dependent. This assay tested cultures at four dilutions and was
performed as previously described, using 10 |j.l culture from the 10"2 through 10"5
dilutions. These dilutions corresponded to infective doses ranging from 10,000 to 10
cells, respectively. As before, insect health was monitored for 60 h and compared to the
corresponding primary parental wild type dosage.
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4. iw vitro insect pathogenesis assay. A) Overnight cultures were standardized to
an OD6oo of 1.0 and serially diluted 10-fold. B) Viable counts were obtained by spread
plating 10 u.1 of each dilution onto LB agar containing pyruvate. C) For each Galleria
mellonella larva, 10 JJ.1 of the appropriate dilution was injected into the hemocoel and 20
larvae in total were injected for each sample. D) Insect mortality was monitored over a 60
h time period.
FIGURE
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PHYSIOLOGICAL ASSAYS

Phenotypic properties of the mutants were determined by the use of standard plate
assays for virulence factors and dye binding as described previously (Hodgson et al.,
2003).

DYE BINDING

Bacteria were streaked onto the following four growth media containing dyes: (1)
MacConkey agar (Difco Laboratories), (2) EMB [2% Proteose Peptone 3 (Remel,
Lenexa, KS), 2% Bacto-Agar, 0.04% Eosin Y, 0.0067% Methylene Blue], (3) NBTA
[2.3% Nutrient Agar (Difco Laboratories), 0.0025% Bromothymol Blue, 0.004%
triphenyl-tetrazolium chloride (TTC)] and (4) LB agar containing calcofluor dye (0.02
mg/mi). For Photorhabdus, the first three indicator media are primarily used to determine
phase variation (Boemare et al., 1997; Hodgson et al., 2003). Inoculated media were
incubated at 28°C for 72 h. Primary phase parental wild type cells form red colonies on
MacConkey, while secondary phase colonies appear light orange or pink. On EMB
medium, primary phase colonies appear shiny metallic green, while secondary phase
colonies are opaque purple. Primary phase colonies on NBTA medium display a dark
green color, while secondary phase colonies are lighter green and pink. Secondary phase
colonies will bind the fluorescent dye, calcofluor, and will fluoresce under UV light. The
primary phase cultures do not bind the calcofluor dye and do not fluoresce under UV
light.
PROTEASE ASSAYS

Besides dye binding, mutants were screened for altered phenotypes involving
secreted products. To assess protease activity, 2 ul of overnight culture was spotted onto
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gelatin plates [2.3% Nutrient Agar (Difco Laboratories), 1.2% gelatin (Difco
Laboratories)] and the radii of clearing zones were measured in mm at 24 and 48 h and
compared to the zones of the primary and secondary parental wild types. At 48 h, a halo
greater than 2 mm was designated positive (+), a halo with a radius of less than 2 mm
was designated intermediate (+/-), and the absence of any clearing zone was noted as
negative (-).

LIPASE ASSAYS

Primary phase Photorhabdus secretes lipase extracellularly. To test for lipase
production in mutants, 2 ul of overnight culture was spotted onto Spirit Blue agar [3.5%
Spirit Blue Agar (Difco Laboratories), 3% (v:v) Bacto-Lipase Reagent (Difco
Laboratories)]. Primary phase parental wild type exhibits a halo around the colony after
48 h incubation at 28°C, while the secondary phase wild type does not. Mutant cultures
displaying a halo with radius greater than 1 mm were noted as positive (+) while the
absence of a halo was designated negative (-).
DNASE ASSAYS

DNase activity of pathogenesis mutants was assessed by spot-inoculating 2 ul
overnight culture onto DNase plates containing methyl green (Difco Laboratories) and
incubated at 28°C. The primary parental wild type produces a 2 mm halo of clearing at 48
h, indicating DNA degradation, while the secondary wild type produces a 1 mm zone.
The radii of clearing zones produced by mutants were measured at 24 and 48 h
incubation.
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ANTIMICROBIAL ASSAYS

Antimicrobial activity was assessed by the agar plug method. Cultures were
grown to confluency on Proteose Peptone 3 agar [2% Proteose Peptone 3 (Remel), 2%
Bacto-Agar, 0.5% NaCl] for 72 h at 28°C and 5-mm-diameter plugs were extracted. The
plugs were placed onto the surface of LB plates inoculated with an overnight culture of
Micrococcus luteus. Plates were incubated overnight at 37°C and zones of inhibition
were recorded in mm (radius).
SIDEROPHORE ASSAYS

To assess siderophore production in hemolysis mutants, 2 ul of an overnight
culture was spot-inoculated onto Chrome Azurol S agar (CAS) (Schwyn and Neilands,
1987) and incubated at 28°C. The radii of resulting halos were measured in mm. An
orange halo greater than 2 mm surrounding the colonies after 48 h incubation indicated
positive siderophore production (+), a radius of less than 2 mm was designated
intermediate production (+/-), and the absence of a halo denoted negative siderophore
production (-).
MOTILITY ASSAYS

Motility in the form of swimming and swarming was assessed for all hemolysis
mutants. Swimming motility (movement through liquid) was assayed as previously
described (Hodgson, 2003). Briefly, overnight culture was stab-inoculated into the center
of swim medium [1% peptone (Difco Laboratories), 1% yeast extract, 0.5% NaCl, 0.25%
Bacto-Agar] and the diameter of swim rings were measured (mm) after 24 and 48 h
incubation at 28°C. Swarming motility (surface movement) was assayed as previously
described (Michaels and Tisa, 2011). Briefly, 2 ul overnight liquid culture was spotinoculated onto the surface of PP3-swarm medium [2% Proteose Peptone 3, 0.5% yeast
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extract, 0.5% NaCl, 0.65% Bacto-agar] and the diameter of swarm rings was measured
(mm) after 24 and 48 h incubation at 28°C.

GROWTH ASSAYS

Cultures were grown overnight in LB broth and subsequently diluted to OD595 of
0.1 in fresh LB medium without kanamycin. Diluted cultures (200 ul) were inoculated
into sterile 96-well polystyrene microtiter plates. The inoculated plates were placed into a
Tecan plate reader with Magellan software (Tecan Group Ltd., Switzerland) and
incubated at 28°C with shaking. The OD595 was measured every half hour for a 24-h
period. The average and standard deviation of each sample was determined from the
replicate wells (n=6) and these values were plotted versus time. The doubling times were
determined for the mutants and the primary and secondary parental wild types.
QUANTITATIVE HEMOLYSIS ASSAY

Confirmed virulence mutants were further assayed for hemolytic activity using a
quantitative liquid hemolysis assay modified from Hertle et al. (1999), and from
Ondraczek et al. (1992). For each mutant, a 48-h liquid culture was assessed for
hemolytic activity with (1) filter-sterilized culture supernatant, (2) bacterial cells washed
with PBS [137 mM NaCl, 2.7 mM KC1, 10 mM phosphate buffer, pH 7.3-7.5 (EM
Science)], and (3) whole-culture suspension in LB broth. Primary and secondary parental
wild type cultures were used for comparative purposes, while 10% sodium dodecyl
sulfate (SDS) served as a positive control and LB as a negative control. For each sample
and controls, 100 ul sample was added to 1 mL washed 10% sheep erythrocytes in PBS
and incubated with agitation at 28°C for 4 h. Absorbance (A405) was measured every hour
and hemolytic activity was calculated using the formula [(A405 Sample - A405 Negative
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control)/A405 Positive control] X 100 = Hemolytic Units. Hemolytic units were plotted
versus time to assess the hemolytic activity of each sample for each mutant compared to
the primary and secondary parental wild types.

MOLECULAR CHARACTERIZATION

Genomic DNA (gDNA) was extracted by the cetyltrimethylammonium bromide
(CTAB) method (Murray and Thompson, 1980) and DNA yield and purity were
determined using the NanoDrop 2000c spectrophotometer (Thermo Scientific,
Wilmington, DE).
The transposon and flanking DNA regions were recovered using a rescue cloning
protocol (Ciche et al., 2001). Ten ug genomic DNA was digested overnight with 10 U
Nsil (New England BioLabs Inc., Ipswich, MA) and subsequently self-ligated using 10 U
T4 DNA ligase (New England BioLabs Inc.) and 50 ul T4 DNA Ligase Reaction Buffer
(10X) in a 500 ul reaction at room temperature overnight. Ligated plasmids were
electroporated into E. coli DH5a using an E. coli Pulser (Bio-Rad Laboratories, Hercules,
CA). Electrocompetent DH5a were prepared by subculturing overnight culture in LB
broth, growing to OD600 0.5-0.7, and performing three washes with ice-cold 1 mM
HEPES {2-[4-(2-Hydroxyethyl)-l-piperazine]ethanesulfonic acid, Acros Organics, New
Jersey} at 4°C before storing cells in 10% glycerol at -80°C. After electroporation,
transformed cells were recovered in SOC medium (2% tryptone, 0.5% yeast extract,
0.058% NaCl, 0.019% KC1, 0.2% MgCl2-6H20, 0.49% MgS04-7H20, 0.36% glucose)
for 2 h at 37°C before plating on LB agar supplemented with kanamycin. Plates were
grown overnight at 37°C and resulting colonies were analyzed for the presence of
plasmid.
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Recovered plasmids were isolated by the use of the QIAprep® Spin Miniprep Kit
(Qiagen Inc., Valencia, CA) according to manufacturer's instructions. Genetic material
flanking the transposon was sequenced using primer M13R-27 (Table 2) and performed
at the Hubbard Center for Genome Studies at the University of New Hampshire (Durham,
NH). Sequence was analyzed using the P. temperata genome available on RAST
[http://rast.nmpdr.org, (Aziz et al., 2008)] and P. luminescens and P.

asymbiotica

genomes available on NCBI's BLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi).

RESTRICTION FRAGMENT L E N G T H POLYMORPHISM

Mutants of interest displaying markedly unusual characteristics were analyzed to
confirm that they were Photorhabdus

cultures and not contaminating organisms.

Polymerase chain reaction (PCR) of the 16S gene region was performed on mutant and
primary parental wild type gDNA (~150 ng) using primers 27F and 1492R (10 uM)
(Table 2). Thermal cycling parameters included initial denaturation at 94°C for 2 min,
followed by 35 cycles of denaturation for 30 sec (94°C), primer annealing for 30 sec
(54°C), and extension for 90 sec (68°C), followed by a final elongation for 5 min at 68°C.
PCR product was purified using the QIAquick® PCR Purification Kit (Qiagen Inc.) and
digested with 10 U Haelll (New England BioLabs Inc.) according to manufacturer's
instructions. Digested DNA was electrophoresed on 2% agarose in IX TAE (40 mM
Tris-acetate, lmM EDTA, pH 8.1-8.5). Fragment sizes of each mutant were compared to
the primary parental wild type.
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Table 2. Primers used in this study
Primer
27F
1492R

F
R

AGA GTT TGA TCA TGG CTC AG
ACG GCT ACC TTG TTA CGA CTT

Primer set (5'-3')

Gene
Universal 16S rRNA
Universal 16S rRNA

Reference
Weisburg et al., 1991
Weisburg et al., 1991

HCP Set 5
HCP Set 5

F
R

CTT AAG CCA CGC GAT AAC ATG AGC
CCT GCG ATA AGG TGA TTC CAG GTA

pte4665 (RT-PCR)
pte4665 (RT-PCR)

This study
This study

M13F(-20)
M13R(-27)

F
R

GTA AAA CGA CGG CCA GTG
GGA AAC AGC TAT GAC CAT G

mini-Tn5
mini-Tn5

Michaels, 2006
Michaels, 2006

PT-KAN-F
PT-KAN-R

F
R

GTA AAC TGG ATG GCT TTC TTG CCG
ATA TCA CGG GTA GCC AAC GCT ATC

Kanamycin resistance
gene of pUB394

Michaels, 2006
Michaels, 2006

Pte3807 Set 5
Pte3807 Set 5

F
R

ATT CGC CAG CTT ACA GGA TGC CTA /rfe3807 (PCR/RT-PCR)
TCG CTG ATA GGC ATG TAA GGC AGT pte3S01 (PCR/RT-PCR)

This study
This study

Pte3808 Set 3
Pte3808 Set 3

F
R

CGT TAT GGG CAA CAT TCC TGG CAA pte3&08 (PCR/RT-PCR)
CTT TCA TCA CGC GCC GGT AAA CAT /?/e3808 (PCR/RT-PCR)

This study
This study

CONFIRMATION OF TRANSPOSON INSERTION SITES

To confirm the location of transposon insertion in the genome, a PCR approach
was used. Primers (10 uM) designed for reverse transcription PCR (Table 2) were used to
amplify genes of interest from approximately 100 ng mutant and wild type gDNA. DNA
regions containing the inserted transposon yielded products approximately 2.5 kb larger
than the expected product size when compared to the primary parental wild type
products. Cycling parameters included an initial denaturation at 94°C for 5 min, followed
by 35 cycles of denaturation for 30 sec (94°C), primer annealing for 30 sec (58°C), and
extension for 3.5 min (72°C), followed by a final elongation for 10 min at 72°C.
Amplified product was subjected to electrophoresis in a 2% agarose matrix in IX TAE
buffer and visualized by ethidium bromide staining.

RNA EXTRACTION

RNA was extracted from mutants of interest and parental wild type cultures.
Overnight cultures were subcultured in fresh LB and grown to OD600 ~0.7 before
harvesting 500 ul using the Qiagen RNAprotect™ Bacteria Reagent and Qiagen
RNeasy® Protect Bacteria Mini Kit according to manufacturer's instructions (Qiagen
Inc.). RNA was eluted from the spin column membrane using 50 ul RNase-free water.
For purification of RNA samples, IX DNase I Reaction Buffer (New England BioLabs
Inc.), 5 U DNase I (New England BioLabs Inc.), 200 U RNaseOUT™ Recombinant
Ribonuclease Inhibitor (Invitrogen Corporation, Carlsbad, CA), and DEPC-treated water
were added to the 50 ul RNA samples to a final volume of 100 ul Samples were
incubated for 30 min at 37°C before inactivation of the DNase I with 1 ul 0.5 M EDTA,
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pH 8.0 (Ambion Inc., Austin, TX), at 75°C for 10 min. RNA yield and purity was
determined using the NanoDrop 2000c spectrophotometer (Thermo Scientific).

REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION

(RT-PCR)

Reverse transcription of mRNA and subsequent cDNA amplification determined
the effect of transposon insertion on transcription for genes of interest. The GoScript™
Reverse Transcription System was used for cDNA first-strand synthesis according to
manufacturer's instructions (Promega Corporation, Madison, WI). RNA (300 ng) and
random primers (0.5 ug) were denatured at 70°C for 5 min before the addition of 1 ul
GoScript™ Reverse Transcriptase, 4 ul GoScript™ 5X Reaction Buffer, MgCl2, 0.5 mM
dNTPs, and nuclease-free water to a final volume of 20 ul. The primers were annealed at
25°C for 5 min and extended at 42°C for 60 min. cDNA was stored at -20°C until
amplification.
Amplification was performed on 500 ng cDNA using 10 uM forward and reverse
gene-specific primers (Table 2). Thermal cycling parameters included initial denaturation
at 94°C for 5 min followed by 35 cycles of denaturation for 30 sec (94°C), primer
annealing for 30 sec (58°C), and extension for 2.5 min (72°C) with a final elongation at
72°C for 7 min. Amplified product was subjected to electrophoresis in a 2% agarose
matrix in IX TAE buffer and visualized by ethidium bromide staining.

SOUTHERN HYBRIDIZATION

Southern hybridization was used to ensure that the phenotypes observed in the
pathogenesis mutants were caused by a single insertion of the transposon into the
genome. For this study, a probe was designed to detect the kanamycin resistance gene of
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the transposon. The kanamycin gene was amplified from 100 ng of the delivery vector,
pUB394, using the PT-KAN primer set (10 uM) (Table 2). PCR product was purified
using the QIAquick® PCR Purification Kit (Qiagen Inc.) according to manufacturer's
instructions and quantified. The Amersham Gene Images AlkPhos Direct Labelling and
Detection System (GE Healthcare, Buckinghamshire, UK) was used to label 200 ng Kan
product according to manufacturer's instructions. The labeled probe was kept on ice for
up to 2 h before use.
For Southern hybridization, 5 ug mutant and primary wild type gDNA were
digested overnight with 5 U Nsil (New England BioLabs Inc.) at 37°C. As a positive
control, 50 ng pUB394 was used. The plasmid was linearized by digesting overnight with
10 U Sacl (New England BioLabs Inc.) at 37°C. Digests were separated in 0.8% agarose
in IX TAE at 6 V/cm and visualized with ethidium bromide. The gel was soaked in 0.25
N HCl for 15 min with gentle agitation to depurinate the DNA, then rinsed with distilled
water. DNA was denatured by soaking the gel in 0.5 M NaOH and 1.5 M NaCl for 30
min with gentle agitation. After rinsing with distilled water, the gel was neutralized for 30
min in 0.5 M Tris-Cl, pH 7.0, 3 M NaCl with gentle agitation and equilibrated in 20X
SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0) for 5 min. A positively-charged nylon
membrane (Amersham Pharmacia Biotech) cut slightly larger than the gel was wetted for
1 min in distilled water and soaked in 20X SSC for 5 min. The equilibrated gel and
membrane were assembled in a reservoir transfer system and the DNA was transferred
overnight using 20X SSC. After transfer, the membrane was washed in 2X SSC for 2 min
and the DNA was fixed to the membrane by baking for 2 h at 80°C between two pieces
of filter paper in a glass dish.
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Prehybridization (15 min) and hybridization (overnight) of the membrane were
performed at 65°C using AlkPhos Direct hybridization buffer (GE Healthcare) containing
0.5 M NaCl and 4% (w:v) blocking reagent with 200 ng Kan probe according to
manufacturer's instructions. Post-hybridization stringency washes were performed at
65°C with primary wash buffer [2 M urea, 0.1% (w:v) SDS, 50 mM Na phosphate, pH
7.0, 150 mM NaCl, 1 mM MgCl2, 0.2% (w:v) blocking reagent] twice, for 10 min each,
followed by two 5-min washes at room temperature with secondary wash buffer (50 mM
Tris base, 100 mM NaCl, 2 mM MgCl2). The membrane was incubated with 40 uVcm2
CDP-Star™ chemiluminescent detection reagent for 5 min before wrapping in plastic
wrap and exposing to radiography film for 1.5 h.
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CHAPTER III

RESULTS

IDENTIFICATION OF HEMOLYSIS MUTANTS

A previously constructed transposon library consisting of approximately 10,000
primary phase P. temperata mutants (Michaels, 2006) was screened for mutants altered in
hemolytic activity. The time of hemolysis initiation for each mutant was observed, and
mutants displaying markedly different activity from the primary parental wild type were
recorded. Primary phase cells displayed annular hemolysis activity between 19 and 24 h
incubation at 28°C, while secondary phase cells showed no hemolytic activity even with
prolonged incubation (72 h). Since individual mutants with elevated or decreased levels
of hemolysis activity were not apparent from this screening protocol, the time required
for the initiation of hemolysis was used as a criterion for mutant identification. Initial
screening identified mutants in two categories: 756 putative early hemolysis mutants and
1,279 putative defective hemolysis mutants. Putative early mutants had clearing zones
visibly larger than the primary parental wild type by 24 h, and putative defective mutants
lacked any halo at 48 h. These hemolysis mutants were subsequently confirmed four
additional times by spotting 2 ul of overnight liquid culture onto blood agar plates.
During this confirmation procedure, a third category, delayed hemolysis, was identified
from the mutants originally thought to be defective. The delayed mutants were separated
based on the initiation of hemolysis between 48 and 72 h, whereas the defective mutants
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had no hemolysis after 72 h. A total of 74 mutants were confirmed and classified as
belonging to one of the three different categories of hemolysin mutant: Defective activity,
Delayed activity, and Early activity (Table 3). Forty-four mutants were grouped into the
defective for hemolysis category and showed no hemolytic activity after 72 h incubation.
Nineteen mutants exhibited a delayed hemolysis phenotype, which was characterized by
initiation of hemolysis activity between 48 and 72 h incubation (approximately 24 h later
than the wild type activity). Eleven mutants had an early hemolysis phenotype, which
displayed hemolysis activity after 14-17 h incubation (approximately 10 h earlier than the
wild type). Confirmed hemolysis mutants were subsequently screened for alterations in
other phenotypes.
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Table 3. Hemolysis screening results: Mutant hemolytic categories
Hemolysis
Defective
Delayed
Early
Primary wild type
Secondary wild type

Mutants Identified
44
19
11
Positive control
Negative control

Description
No hemolysis activity after 72 h
Initiation of hemolysis between 48 and 72 h
Initiation of hemolysis before 17 h
Initiation of hemolysis between 19 and 24 h
No hemolysis activity after 72 h

PHYSIOLOGICAL CHARACTERIZATION OF THE HEMOLYSIS MUTANTS

A variety of physiological traits were assessed for the 74 hemolysis mutants and
compared to the primary and secondary parental wild types (Table 4). Dye binding and
pigmentation were used to assess the phenotypic phase of each mutant to ensure that
altered hemolytic activity was not attributed to phase variation. Extracellularly-secreted
products including protease, lipase, siderophore, and antimicrobials were evaluated.
These are all potential virulence factors and are used to distinguish the primary and
secondary phenotypic variants as well. Lastly, swimming and swarming behavior were
measured for each mutant to identify altered motility.
The majority of the hemolysis mutants had all or most of their phenotypes
resemble those of the primary parental wild type. The most physiological variation was
observed in the defective hemolysis group; 19 of the 44 mutants had strictly primary
characteristics, while 17 mutants displayed a mix of predominantly primary traits with
some secondary characteristics. Within this group were 5 mutants defective for protease,
one mutant defective for lipase, one mutant defective in both lipase and protease, 3
mutants defective in swarming motility, 3 mutants defective in swimming motility, one
mutant defective in both swimming and swarming, two lacking colony pigmentation, and
one defective in dye binding, lipase, antibiotic production, swimming, and swarming.
Only 8 defective hemolysis mutants displayed primarily secondary characteristics;
however, none of these mutants had phenotypes that were entirely secondary. These data
indicate that all mutants were primary variants, but that the transposon insertion often
disrupted phenotypes other than hemolysis. All 19 delayed hemolysis mutants displayed
mostly primary phenotypes, only resembling the secondary in, at most, two
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characteristics for any given mutant (5 mutants were strictly primary). Interestingly, 6 of
the delayed hemolysis mutants were unable to grow on the CAS siderophore media.
There was one mutant defective for swarming, two defective for swimming, one
defective for both swimming and swarming, one defective for antibiotic production and
swimming, one with reduced siderophore activity, one that bound calcofluor, and one that
bound calcofluor and could not swarm. Lastly, all early hemolysis mutants, with the
exception of 86 C7, were physiologically identical to the primary parental wild type.
Since hemolysis mutants were identified based on early or delayed activity, the
effects of growth rate needed to be considered. Growth assays were performed on all 74
hemolysis mutants (Data not shown). The majority of mutants exhibited growth rates
similar to the primary phase parental wild type. For the early hemolysis mutants, 9 out of
the 11 mutants also had growth rates similar to the parental wild type; however, two early
hemolysis mutants (86 C7 and 82 HI2) actually displayed growth rates that were slower
than that of the parental wild type (Figure 5). These results indicate that the altered
hemolysis activity observed for these mutants was not the consequence of altered growth
rates.
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Table 4. Physiological properties of P. temperata mutants altered in hemolvtic activity and their parental wild types
Strain
Parental:

Pigment

EMB

MAC

NBTA

Calc

1°WT
2°WT
Defective:
10AC11
10AH12
11AD12
12AG7
2H12
5A12
22 A2
24G12
36 CIO
37 CI
38D10
38 E l l
40D10
40 E7
41 B3
46 G6
47 H6
50 C5
51 F9
53 H3
56 H7
60 A2

Dark
Light

+
-

+
-

+
-

+

Light
Light
Dark
Light
Light
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Light
Dark
Dark
Dark
Dark
Dark
Dark
Dark

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+/+/+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+/•

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
„

Lipase

Protease

T

T

-

+

_

+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
NG
_

+/•

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

Antibiotic

CAS

Swim

Swarm

4
0

+
+

45
10

85
13

1
1
4
2
1
3
3
4
3
4
3
3
4
5
4
4
3
3
3
2
3
4

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

10
9
50
11
16
34
35
41
28
27
29
40
36
34
36
12
26
28
26
4
31
40

10
9
54
10
11
25
85
58
45
30
55
85
55
56
50
12
32
29
54
9
78
85

Table 4 (cont.)
Strain
65 B5
65 CIO
69 Dl
71 H4
72C12
78 E3
79 B5
79G12
80 A l l
81 C4
81 E2
81 F5
82A12
82B11
82 D2
83 Al
83 El
84 El
84H11
89 F5
90 B9
90 E2

Pigment
Dark
Dark
Dark
Light
Dark
Dark
Light
Dark
Dark
Light
Dark
Dark
Dark
Dark
Dark
Light
Dark
Dark
Dark
Light
Dark
Dark

Lipase

Protease
NG
+
+
+
+
+
+
+
+
+
+
+
+
+
+

EMB
+
+
+

MAC
+
+
+

NBTA
+
+
+

Calc

-

-

-

+

-

+
+
+
+
+

+
+
+/+
+

-

-

-

+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+

-

+
+
+
+
+
+
+
+
+
+
+

-

-

-

+

-

-

+
+
+

-

-

-

+
+

+
+
+

+
+
+

+
+
+

-

-

-

-

+

-

+
+
+
+

+
+

+
+

+
+

.

+
+

-

Antibiotic
6
4
4
0
4
3
4
4
4
0
5
6
6
6
5
0
5
+
5
0
6
5

CAS
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+/+
+
+
+
+
+

Swim
29
49
37
30
43
40
38
38
31
11
33
33
11
25
15
36
NG
29
24
34
20
36

Swarm
43
46
29
15
7
20
10
75
80
70
85
85
85
85
85
10
85
75
85
21
85
85

Table 4 (cont.)
Strain
Delayed:
26 C4
26 E6
30 C6
30 F2
32 C5
32 E4
34 E2
36 D6
37 C5
38A10
40 E6
41 D5
59 G4
62 A7
65 D5
67 HI
69 H6
72 F9
86 G2

Pigment

EMB

MAC

NBTA

Calc

Lipase

Protease

Antibiotic

CAS

Swim

Swarm

Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+/+
+
+
+/+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

-

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

5
4
5
5
5
4
5
4
5
4
6
5
0
5
5
5
6
5
4

NG
+
NG
+
NG
NG
NG
+
+
+
+
NG
+
+
+
+/+
+
+

42
3
45
23
40
45
45
35
30
30
36
38
22
24
22
35
31
42
31

85
8
85
9
85
80
85
69
9
36
48
85
55
53
85
85
85
85
70

+
-

+
-

Table 4 (cont.)
Strain
Pigment
Early:
9AF6
24 A4
27G12
35 B9
36 D3
38 CIO
38 G3
59 G6
61 E8
82H12
86 C7

Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Dark

EMB

MAC

NBTA

Calc

Lipase

Protease

Antibiotic

CAS

Swim

Swarm

+
+
+
+
+
+
+
+
+
+
-

+
+
+
+
+
+
+
+
+
+
_

+
+
+
+
+
+
+
+
+
+
_

+

+
+
+
+
+
+
+
+
+
+
_

+
+
+
+
+
+
+
+
+
+
+

4
4
4
4
4
4
4
4
4
5
2

+
+
+
+
+
+
+
+
+
+
+/-

40
66
43
55
53
35
61
69
40
47
43

85
85
85
85
85
85
85
85
85
85
85

Pigment: Determined by growth on LB agar. Dark pigmented colonies appear orange or yellow in color while light colonies appear
white or off-white. EMB (Eosin Methylene Blue): Positive (+) dye absorption was indicated by shiny metallic green colonies, while
negative (-) colonies were pink or purple. MAC (MacConkey): Positive colonies were red colored while negative colonies were pale
pink or orange (+/- denotes light red colonies less pigmented than the 1° but more than the 2°). NBTA (Nutrient Bromothymol Blue
Agar): Positive colonies were dark green while negative colonies were light green or pink (+/- denotes green colonies of medium
shade). Calc (Calcofluor): Positive binding of calcofluor fluoresced under UV light while negative did not fluoresce. Lipase and
Protease: Positive reactions were indicated by a halo around the colony (>1 mm for lipase, >2 mm for protease), while negative
reactions lacked a halo (+/- on protease indicates a halo of <2 mm). Antibiotic: The radius of clearing surrounding each colony was
recorded in mm. CAS (Chrome Azurol S): Positive siderophore production was noted by an orange halo (>2 mm) surrounding the
colony, while negative production lacked such a halo (+/- indicates a halo <2 mm). Swim and Swarm: The diameters of swim and
swarm rings were recorded in mm at 48 h incubation. NG (No growth): Repeated culturing attempts yielded no growth of some
mutants on certain media. All data were recorded at 48 h incubation at 28°C.

IDENTIFICATION OF PATHOGENESIS MUTANTS

We were interested in the role that hemolysis activity plays in insect pathogenesis
and tested this property by the use of an in vitro insect pathogenesis assay. Standardized
numbers of cells for mutants and parental wild type were injected directly into the
hemocoel of Galleria mellonella larvae and insect mortality was monitored over time as
described in the Methods. Figure 6 shows the representative results for the parental wild
types and select mutants. Virulence was determined by calculating the time required to
kill 50% of the larval population infected (LT50) and the time required to kill the entire
population (LTioo). Although the exact times varied by data set, the primary phase
parental wild type killed half of the infected larvae on average by 47 h (LT50) and the
entire larval population on average by 55 h (LTioo). Secondary phase parental wild type
cells were more virulent and had an average LT50 and LTioo of 44 h and 50 h,
respectively. All of the hemolysis mutants killed the insects; however, none of the
mutants killed faster than the parental wild type. For the mutants defective in hemolytic
activity, 15 out of the 44 mutants were also defective in pathogenesis during initial
screening (Table 5). These mutants showed a delayed pathogenesis response that was 1020 h later than the primary phase parental wild type (Figure 6). For the delayed hemolysis
group, 10 out of the 19 mutants also exhibited a delayed response for pathogenesis. All of
the 11 early hemolysis exhibited a pathogenesis response similar to the parental wild
type. These results indicate that hemolysis activity is not required for insect killing, but
may play a role in the pathogenesis process. The 25 mutants altered in both hemolysis
and insect pathogenesis were selected for further study.
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6. The in vitro insect pathogenesis assay identified 25 hemolytic mutants that exhibited a delayed response in pathogenesis.
The delayed pathogenesis response was characterized by an increase in the LT50 and LTioo by >10 h compared to primary parental
wild type. Representative data points for two mutants are shown above. The other 20 putative virulence mutants showed similar trends
(Table 5).
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Table 5. Hemolysis mutants altered in insect pathogenesis as identified by preliminary
screening. An in vitro insect pathogenesis assay was used to determine LT50 and LTioo as
described in the Materials and Methods. For these assays, 100 cells were inoculated into
each of 20 larvae.
Mutant
1°WT
2°WT
10AC11
10AH12
46 G6
50 C5
53 H3
79 B5
30 C6
30 F2
32 C5
34 E2
12AG7
2H12
24G12
51 F9
56 H7
60 A2
84 El
89 F5
90 E2
26 C4
26 E6
32 E4
36 D6
41 D5
59 G4

Hemolysis
+
-

Defective
Defective
Defective
Defective
Defective
Defective
Delayed
Delayed
Delayed
Delayed
Defective
Defective
Defective
Defective
Defective
Defective
Defective
Defective
Defective
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed

LT 50
47
44
59
59
60
60
>68
71.5
57
57
56
53
55.5
59
58.5
>57
52
>52.8
56
56
55.5
56
>58
57.5
62.5
>61
53

LTioo
55
50
69
68
69
66
>68
91.5
65
65
65
65
64.5
>59
71.7
>65
68
>52.8
>56
>56
>56
77.5
>58
67.5
71.5
>61
64

MOI
Confirmed
-

YES
YES
YES
YES
YES
YES
YES
YES
YES
YES
-

Mutant LT50 and LTioo values were standardized to the average LT50 and LTioo of the
primary parental wild type. Initial pathogenesis testing identified 25 putative virulence
mutants. Multiplicity of infection (MOI) assays performed with four different infectious
doses confirmed 10 mutants that remained delayed in pathogenesis by 10 or more h after
injection with each dose.
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CONFIRMATION OF PATHOGENESIS MUTANTS

The effect of cell dosage on insect pathogenesis was determined for the 25
identified hemolysis mutants. Figure 7 shows the results of representative mutants
compared to the parental wild type. Multiplicity of infection (MOI) was tested by the use
of variable infectious doses ranging from 10 to 10,000 cells (four doses for each mutant).
MOI assays showed that 10 out of the 25 hemolysis mutants that displayed reduced
virulence during the initial screen maintained their delayed virulence. These confirmed
pathogenesis mutants were 10A Cll, 10A H12, 30 C6, 30 F2, 32 C5, 34 E2, 46 G6, 50
C5, 53 H3, and 79 B5. Only those mutants that were consistently delayed by 10 h at each
of the four dosages were counted; mutants that were delayed at some of the doses but not
all were not considered true pathogenesis mutants. Typically, these mutants would
exhibit delayed pathogenesis at lower dosages, but as the cellular density increased, the
mutants had close to wild type pathogenesis, likely due to the accumulation of toxins
produced. Of the 10 confirmed pathogenesis mutants, seven were defective for hemolysis
and four had delayed hemolysis (Table 6).
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FIGURE

FURTHER PHENOTYPIC CHARACTERIZATION OF
CONFIRMED PATHOGENESIS MUTANTS

The ten confirmed pathogenesis mutants were selected for a more quantitative
look at physiological characteristics. These mutants were again assayed as previously
described (Table 4) with the inclusion of DNase activity. Clearing zones and halos for
lipase, protease, antimicrobial activity, siderophore production, and DNase activity were
measured in mm (radius), and the diameters of swim and swarm rings were quantified as
well (mm) (Table 6). Interestingly, all of the ten mutants were altered in at least one
additional phenotype; no mutants were altered only in hemolysis and pathogenesis. A
closer look at these ten mutants reveals that two of the defective hemolysis/delayed
pathogenesis mutants, 10A Cll and 10A HI2, appear identical and may have sibling
mutations. As mentioned previously, no mutants entirely lack primary characteristics.
Interestingly, 30 C6, 32 C5, and 34 E2, which are delayed hemolysis/delayed
pathogenesis, all have increased production of protease and antibiotics compared to the
primary parental wild type, and are unable to grow on the siderophore medium, again
indicating possible mutations in the same gene. 46 G6 is impaired in both swimming and
swarming motility, and mildly defective in protease, DNase, and siderophore production,
however retains wild type levels of lipase and antibiotic production. 53 H3 is nonmotile,
has decreased secretion of protease, antibiotics, and siderophore, and does not grow on
lipase medium. 79 B5 has decreased protease, siderophore, and DNase activity, and is
defective for swarming. 50 C5 has decreased secretion of all extracellular products,
except for DNase. 30 F2 has increased antibiotic activity, decreased siderophore activity,
and is unable to swarm. The wide variations in phenotypes observed even within this
small group of mutants demonstrate the diversity of genes affecting virulence.
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Table 6. Quantitative physiological analysis of 10 mutants altered in hemolytic activity and delayed in virulence
Strain
1°WT
2°WT
10AC11
10AH12
30 C6
30 F2
32 C5
34 E2
46 G6
50 C5
53 H3
79 B5

Hemolysis
+
-

Defective
Defective
Delayed
Delayed
Delayed
Delayed
Defective
Defective
Defective
Defective

Pigment
Dark
Light
Light
Light
Dark
Dark
Dark
Dark
Dark
Dark
Dark
Light

Dye Binding
+

Calc

-

+
+
+

+
+
+
+
+
+
+/+/-

-

-

+
-

+
-

Lipase
2
0
0
0
2
2
2
2
2
1
NG
2

Protease
3
2
1
1
4
3
4
4
2
2
1
2

Antibiotic
4
0
1
1
5
5
5
5
4
3
2
4

CAS
5
4
4
4
NG
4
NG
NG
4
3
2
2

DNase
2
1
1
1
2
2
2
2
1
2
2
1

Swim
52
10
10
9
45
23
40
45
12
28
4
38

Swar
85
13
10
9
85
9
85
85
12
29
9
10

Hemolysis activity determined as previously described (Table 3). Pigment: Determined by growth on LB agar. Dark pigmented
colonies appear orange or yellow in color while light colonies appear white or off-white. Dye binding determined by absorbance of
dyes on EMB, MAC, and NBTA as previously described (Table 4). Calc (Calcofluor): Positive binding of calcofluor fluoresced under
UV light while negative did not fluoresce. Extracellular secretion of lipase, protease, antibiotics, and siderophore quantified by
measuring the radius of zones/halos in mm. DNase: Production of DNase was indicated by a halo around the colony. The radius of
clearing surrounding each colony was recorded in mm. Swim and swarm: The diameters of swim and swarm rings were recorded in
mm at 48 h incubation. NG (No growth): Repeated culturing attempts yielded no growth of some mutants on certain media.

QUANTIFICATION OF PATHOGENESIS MUTANT HEMOLYTIC ACTIVITY

A liquid hemolysis assay was used to quantify the amount of blood lysing activity
in the 10 pathogenesis mutants. Samples were measured over a four hour time period and
hemolytic units were calculated and plotted over time. The hemolytic activity of each
mutant was compared to the primary parental wild type. Figure 8a shows two
representative mutants compared to the parental wild types. 79 B5 exhibited a delay in
the initiation of hemolysis, but once lysing began, the activity followed the same trend as
the primary. The collective data showed that, although all of the mutants were in some
way inhibited for hemolysis on blood agar plates, they retained blood lysing activity in
the liquid assay (Table 7). A few mutants actually showed hemolytic activity earlier than
the primary. Hemolytic activity was also present in the secondary wild type, which is
negative for hemolysis on blood agar. The secondary variant had hemolytic activity equal
to that of the primary; however, the level of hemolysis was decreased in some mutants.
Each culture was tested for hemolysis using a diluted culture sample, a PBSwashed cell sample, and a filter-sterilized supernatant sample. Figure 8b compares the
three sample types for the primary parental wild type. For each culture, wild type and
mutant alike, the highest hemolytic activity was observed in the diluted culture sample
(Data not shown). Hemolysis was detected in the washed cell samples, but was greatly
decreased. None of the samples showed any hemolysis in the supernatant samples. These
data indicate that the presence of bacterial cells is required for hemolysis, but the activity
is enhanced by the presence of culture medium as well.
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Table 7. Hemolytic units of parental wild types and pathogenesis mutants over time in a
liquid hemolysis assay using diluted culture
Strain
1°WT
2°WT
10AC11
10AH12
30 C6
30 F2
32 C5
34 E2
46 G6
50 C5
53 H3
79 B5

Hourl
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Hour 2
0.00
0.00
0.13
0.00
0.78
0.00
0.00
0.35
0.00
0.00
0.00
0.00

Hour 3
0.73
0.59
0.55
0.64
0.70
1.41
1.21
1.73
0.56
0.70
0.59
0.12

Hour 4
1.98
2.51
1.65
2.00
1.34
1.98
1.68
2.67
1.90
1.34
1.44
0.94

50 C5 and 53 H3 were tested separately and have been standardized to the primary
parental wild type in this data set. All mutants and wild types showed an increase in
hemolysis over time.
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MOLECULAR CHARACTERIZATION OF VIRULENCE MUTANTS

Several of the hemolysis mutants were analyzed at the genetic level to identify
the site of transposon insertion.

SOUTHERN HYBRIDIZATION TO CONFIRM SINGLE INSERTIONS

Southern hybridization was performed to verify that there was only one
transposon insertion in the genomes of the ten pathogenesis mutants. The transposon is
designed to insert only once into the genome; however, multiple insertions can occur,
which could possibly explain the altered effects on both hemolysis and virulence in these
mutants. A fluorescently-labeled probe designed to bind to the kanamycin gene was used
to identify the number of insertions in each mutant. Multiple insertions would be visible
as multiple bands on the blot; however, only one band was seen for each sample. Results
from Southern hybridization revealed that all ten of the pathogenesis mutants contained a
single transposon insertion in the genome (Figure 9).
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9. Southern blotting confirmed single transposon insertions for the pathogenesis
mutants. One band was detected by the fluorescently-labeled Kan probe for each sample.
A: pUB394 positive control, B: 10A C l l , C: 10A H12, D: 30 C6, E: 30 F2, F: 32 C5, G:
34 E2, H: 46 G6,1: 50 C5, J: 53 H3, K: 79 B5, L: primary wild type negative control.
FIGURE

56

IDENTIFICATION OF TRANSPOSON INSERTION SITES

Rescue cloning was used to identify the specific site of the transposon insertion.
The transposon and flanking gene region was recovered via rescue cloning and plasmid
sequencing. Sequencing of the rescued plasmid determined the genes disrupted by the
transposon (Tn5). The sequenced plasmids were compared to the P. temperata NCI9
genome, providing a good database for site identification. The availability of the P.
luminescens subsp. laumondii TT01 and P. asymbiotica subsp. asymbiotica ATCC 43949
genomes also provided a good baseline for comparison. The insert site for 16 mutants
displaying different hemolytic and pathogenic phenotypes were identified (Table 8).
Interestingly, although the P. temperata genome contains at least 24 hemolysis genes,
none of the 16 characterized mutants had the transposon inserted into genes directly
involved in hemolysis. Instead, the observed phenotypic defects were due to disruptions
in genes mainly involved in outer membrane proteins, export systems, and RNA
degradation. A few mutants had disruptions in other types of genetic elements, including
a transposase and a phage repressor protein. Of particular interest, however, were those
mutants confirmed to have alterations in both hemolysis and virulence.
Genes for eight pathogenesis mutants were identified: 10A Cll, 10A HI2, 30
C6, 30 F2, 46 G6, 50 C5, 53 H3, and 79 B5. Mutants 10A Cll, 10A H12, and 79 B5 had
disruptions in genes involved in RNA degradation. 10A Cll and 10A H12 mapped to a
gene encoding Exoribonuclease II, a gene previously identified in a mutant altered in
motility and pathogenesis (Rowedder, 2009). 79 B5 mapped to a gene encoding an
adenosine (5')-pentaphospho-(5")-adenosine pyrophosphohydrolase, which belongs to the
nudix superfamily of RNases. Additional pathogenesis mutants identified several
hypothetical proteins (30 F2 and 50 C5), an LPS heptosyltransferase I (53 H3), a
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carbamoyl-phosphate synthase large subunit (30 C6), and a transposase (46 G6). 46 G6
mapped to a transposase with seven identical paralogs in the genome. Additional
sequencing with forward primer M13F determined that the transposon had been inserted
in pte4664, the transposase located on contig 9, which is adjacent to a secreted protein
Hep (hemolysin co-regulated protein), part of the Type VI secretion system.
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Table 8. Transposon insertion sites for mutants of interest
Identity
Mutant
(%) E value
Gene
Defective hemolysis/
WT virulence
22 A2
41 B3
51 F9
71 H4
90 E2
••o Defective hemolysis/
Delayed virulence
10AC11
10AH12
46 G6
50 C5
53 H3
79 B5

835/839 (99%)
E = 0.0
934/936 (99%)
E = 0.0
773/773 (100%)
E = 0.0
420/420(100%)
E = 0.0
943/944 (99%)
E = 0.0

P/e3758

942/943 (99%)
E = 0.0
919/928 (99%)
E = 0.0
911/919(99%)
E = 0.0
942/944 (99%)
E = 0.0
518/518(100%)
E = 0.0
945/945 (100%)
E = 0.0

Pte626

Pte4458
P/e2343
P/e4077
P/e3758

Pte626
Pte4664
Pte2343
Pte4736
P/e3808

Plu or Pau
homologue

P/w0658
Paw00608
P/w4762
Paw04250
P/w3152

Insert Site

1301
259
291

Predicted/Postulated
Gene function

Membrane Fusion Protein
PrtC
ATP-dependent protease
HslV
Conserved hypothetical
protein
Similarities with repressor
protein CI
Membrane Fusion Protein
PrtC

P/w4545
Paw04046
P/w0658
Paw00608

395

P/w2384
Paw02113
P/i/2384
Pm/02113
P/w3016
Paw01660
P/w3152

1279

Exoribonuclease II

1279

Exoribonuclease II

155

Transposase

291

Conserved hypothetical
protein
Lipopolysaccharide
heptosyltransferase I
Adenosine (5')pentaphospho-(5 ")adenosine
pyrophosphohydrolase

Plu4849
Pau04355
P/w0620
Pau00579

191

285
147

Table 8 (cont.)
Mutant
Delayed hemolysis/
WT virulence
32 E4
41 D5
Delayed hemolysis/
Delayed virulence
30 C6
30 F2

en
O

Early hemolysis/
WT virulence
86 C7

Identity
(%) E value

Gene

570/570 (100%)
E = 0.0
777/778 (99%)
E = 0.0

Pte3828

935/935 (100%)
E = 0.0
677/677 (100%)
E = 0.0

Pte3828

932/934 (99%)
E = 0.0

Pte\24\

Pte3828

Plu or Pau
homologue

Insert Site

P/w0604
Paw00562
P/w0604
P«w00562

2638

P/w0604
Paw00562

746

Pte4759

756

1153

P/wl619
Pa«02831

Predicted/Postulated
Gene function
Carbamoyl-phosphate
synthase large chain
Carbamoyl-phosphate
synthase large chain
Carbamoyl-phosphate
synthase large chain
Hypothetical protein
(*adjacent to UDPglucose 4-epimerase)
Phosphoserine
aminotransferase

Identity (%) E value: Determines percentage of sequenced nucleotides with exact matches in the genome for the identified gene. Gene:
pte number identifies sequence location in P. temperata genome. Plu or Pau homologue: plu and pau numbers identify location of
matching gene in P. luminescens and P. asymbiotica genomes, respectively. Insert Site: Identifies the location of transposon insertion
within the gene. Gene function: Putative product produced by the identified gene, based on sequence similarities with other closely
related genomes.

CONFIRMATION OF TRANSPOSON INSERTION SITES BY PCR

To confirm the location of the transposon insertion identified by rescue cloning,
two PCR approaches were used. Initially, primers (Table 2) were used to amplify the
genes of interest from genomic DNA. Product sizes were compared to products amplified
from the primary parental wild type genomic DNA. The presence of the transposon
within a particular gene results in a product size approximately 2.5 kb larger than the
expected product size. This size discrepancy allowed us to determine which gene housed
the transposon in one particular mutant of interest, 79 B5, where sequencing had
indicated a possible overlap of two genes by the transposon.
Sequencing of the rescued plasmid from 79 B5 identified a transposon insertion
site 147 bases into pte3S0S, a gene encoding a nudix protein involved in RNA
degradation. Immediately adjacent to this gene is pte3807, a nitrogen regulationassociated phosphocarrier protein kinase/phosphorylase. The expected product size for
amplification of pte380S from genomic DNA with the RT-PCR primers (Table 2) is 370
bp, as observed in the 1° WT sample (Figure 10a); however, amplification of pte3S0S
from mutant 79 B5 yielded a product greater than 3.0 kb, confirming the presence of the
transposon within this gene. The expected product size of amplified pte3&07 is
approximately 0.7 kb, which was observed in both the 1° WT and 79 B5 samples,
indicating that the transposon does not overlap pte3807.
In addition to amplifying the genes from genomic DNA to verify transposon
location, RT-PCR was used to determine any potential downstream effects of insertion
for mutants of interest. End-point RT-PCR can determine whether a gene is expressed
and transcript is made, or whether the insertion of the transposon has impeded gene
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expression. Mutant 79 B5 was analyzed for transcription of bothjo/e3808, the location of
transposon insertion, andpte3807, the adjacent downstream gene. For both the 1° and 2°
parental wild types, ample transcript of both pte380S and/?te3807 was present (Figure
10b). 79 B5 lacked transcript for pte3808, indicating that transposon insertion had
knocked out all expression of this gene. 79 B5 did, however, retain expression of
pte3807, demonstrating that the interruption in pte3808 did not have an effect on the
expression of downstream genes. This confirmation indicates that pte3808 is not located
within an operon, and that 79 B5 is a candidate for genetic complementation.
End point RT-PCR was also performed on 46 G6, the mutant with the
transposase adjacent to the Hep locus. Since Hep is putatively involved in hemolysin
activity, we wanted to see if the transposon insertion had downstream effects on this
gene, causing the observed phenotypes. RT-PCR on Hep with HCP Set 5 primers (Table
2) showed that transcript was actually being made for this gene (Data not shown). This
result indicates that the transposon insertion in/?te4664, the transposase, did not have
downstream effects on Hep expression.
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10. Confirmation of transposon insertion sites via PCR. a) PCR of genomic DNA yielded products of different sizes,
confirming transposon location. A: 2-Log DNA Ladder, B: 1° WTpte3808, C: 79 B5;?te3808, D: 1° WT/?te3807, E: 79 B5pte3807,
F: 1° WT>te3808 F with/tfe3807 R, G: empty, H: 79 B5 pte3808 F withpte3807 R, I: 2-Log DNA Ladder, J: pte3808 no template
control, K: pte3807 no template control, L: pte3808 F with/?fe3807 R no template control, b) End-point RT-PCR confirmed there
were no downstream effects of transposon insertion. A: 2-Log DNA Ladder, B: 1° WT pte3808 transcript, C: 2° WT pte3808
transcript, D: 79 B5pte3808 transcript, E: empty, F:pte3808 transcript no template control, G: empty, H: 1° WTpte3807 transcript, I:
2°pte3807 transcript, J: 79 B5pte3807 transcript, K: empty, L: pte3807 transcript no template control.
FIGURE

CHAPTER TV

DISCUSSION

IDENTIFICATION O F MUTANTS A L T E R E D IN HEMOLYSIS AND PATHOGENESIS

Previous research conducted on the pathogenesis of Photorhabdus has begun to
elucidate the virulence mechanisms employed by this organism. However, despite
advancements in our understanding of the physiology of Photorhabdus, little knowledge
exists on the precise function and mechanisms of the hemolysins in this system. The
goals of this study were to investigate the hemolytic activity of Photorhabdus and to
identify the relationship between hemolysis and pathogenesis. To accomplish these goals,
a series of screening procedures were employed. Initially, a previously constructed
10,000-transposant library containing primary phase mutant P. temperata was screened
for altered hemolytic activity using a sheep blood agar plate assay. For this screening
procedure, time to initiation of hemolysis was used as the criterion for discerning mutants
from the wild type. The screen was conducted this way because the plate assay is a
qualitative assessment of hemolysis; increased or decreased levels of activity are not
identifiable with this method. For a quantitative analysis of hemolytic activity, a liquid
hemolysis assay is necessary. This quantitative assay is significantly more labor intensive
than the plate method, rendering the screening of this volume of mutants unfeasible. The
liquid assay is more suitable for analyzing a smaller subset of mutants, such as the 10
pathogenesis mutants identified in this study.
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The object of screening the library was to identify mutants that were altered in the
synthesis, regulation, or secretion of hemolysins; therefore, identified hemolysis mutants
were categorized into one of three groups: Defective, Delayed, and Early. By using these
classifications, I expected to find some representative types of mutations. I expected that
the defective hemolysis mutants, in which hemolytic activity had been completely lost,
would contain disruptions in genes related to hemolysin synthesis. Delayed and early
hemolysis mutants would therefore likely represent mutants with disruptions in transport
mechanisms and regulators or suppressors of hemolysis activity. In reality, I identified
mainly genes involved in regulation and transport, but none directly related to hemolysis.
Although labor-intensive, screening the library in this way offers several distinct
advantages over site-directed mutagenesis for the investigation of hemolysis. The P.
temperata genome contains at least 24 genes putatively involved in hemolysis. Direct
knock-outs of these genes may be useful for understanding the role of each specific gene
in hemolysis, but would not identify additional regulatory elements indirectly involved in
hemolysis expression.
A second advantage of screening the library directly is that it generates a smaller
pool of mutants that can be tested for pathogenesis. The in vitro pathogenesis assay used
in this study is another labor-intensive process; testing the entire transposant library for
mutants altered in pathogenesis is not feasible. Therefore, smaller groups of mutants are
characterized for virulence. Previously, 86 identified motility mutants were tested for
pathogenesis (Michaels, 2006; Rowedder, 2009), and in this study, 74 hemolysis mutants
were tested. Although site-directed mutagenesis of hemolysis genes would also create a
mutant pool for testing, screening the entire library identifies a larger group of mutants
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with a broader range of mutations, thus providing more opportunities to identify genes
involved in pathogenesis.
The P. temperata genome is approximately 5 Mb in length, encoding roughly
5,000 genes. When the transposon library was constructed, it was designed to give 2x
coverage of the genome, hence the 10,000 primary-phase mutants. Theoretically, every
gene in the genome should then be represented by two mutants. Given that P. temperata
has 24 putative hemolysin genes, I expected to find approximately 48 mutants with
disruptions in hemolysis genes. I also expected to find a number of pleiotropic mutants
with disruptions in global regulators and other indirectly-related genes. However, the
insertion of the transposon appears to be biased. This means that the Tn5 has a tendency
to recognize hot spots in the genome, resulting in many mutants having insertions in the
same gene. I observed this in my study as well; I identified four groups of mutants with
insertions in the same genes. None of the 16 mutants for which I identified the site of
transposon insertion had disruptions in hemolysis genes. I believe this is due to bias in
choosing which mutants to characterize on the genetic level. Although I did find 34
mutants that were altered only in hemolysis, the mutants altered in both hemolysis and
pathogenesis were of primary interest in this study, followed by hemolysis mutants that
displayed other pleiotropic effects. Choosing these mutants to characterize probably
decreased my chances of identifying genes directly related to hemolysis, as those mutants
most likely were only affected in hemolysis expression.
The methods used in this study were designed to provide a broader understanding
of the genetics involved in the hemolysis and pathogenesis of Photorhabdus. The genes
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and their pleiotropic effects identified in this study contribute new data to the growing
insight into the physiological mechanisms of Photorhabdus.

MULTIPLE HEMOLYSINS ARE ACTIVE IN PHOTORHABDUS

Although all of the pathogenesis mutants were either defective or delayed for
hemolysis on blood agar plates, I expected that these mutants would retain some
hemolytic activity in a liquid assay. Data mining in the RAST and IMG (integrated
Microbial Genomes; http://img.jgi.doe.gov/) databases identifies 24 putative hemolysin
genes in the P. temperata genome, 25 in the P. luminescens genome, and 18 in the P.
asymbiotica genome. These numbers indicate that Photorhabdus most likely contains a
variety of different hemolysins and genes involved in the regulation of hemolysis.
Moreover, Xenorhabdus has been shown to contain multiple hemolysins which are
independently regulated and active at different stages of stationary phase (Brillard et al.,
2001). The findings from the liquid assay showed that the 10 pathogenesis mutants did
have some hemolytic activity when in liquid culture. These data support the notion that
Photorhabdus encodes multiple types of hemolysin, or has paralogs encoding the same
hemolysins. This result was expected given the number of putative genes involved in
hemolysin expression. This is also consistent with a study by Brillard et al. (2002), which
showed evidence of at least two hemolysins in Photorhabdus, and demonstrated that
PhlA activity was only detected using a liquid assay. It is likely that some hemolysins
may require close cellular contact with the blood cells in order to induce lysis. This may
explain why hemolysis was not visible on blood agar, but was detected in liquid culture
where the bacterial cells are able to constantly mix with the blood cells.
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Another interesting finding from this assay was that the secondary wild type had
hemolytic activity that was equal to, if not slightly higher than, the primary wild type.
This finding further supports the idea that different hemolysins are active via different
mechanisms. Furthermore, the hemolysins producing annular ring formation on the plate
assay are not the same as those active in liquid culture. This notion is consistent with
previous findings of hemolytic activity in the secondary phase (Brillard et al., 2002).

HEMOLYTIC ACTIVITY IN PHOTORHABDUS IS CELL-ASSOCIATED

In 2001, Brillard et al. showed that active hemolysin was secreted from
Xenorhabdus into the extracellular medium, and that the culture supernatant retained
hemolytic activity. In contrast, Photorhabdus culture was not shown to have a secreted
hemolytic compound (Brillard et al., 2001; Brillard et al., 2002). To test this study, I
performed a liquid hemolysis assay using three sample types for each culture. My
findings confirm the findings of Brillard et al.; bacterial cells must be present in the
sample for hemolysis to occur. Furthermore, the highest hemolytic activity is achieved
when cells and culture medium are used together. What this may indicate is that the
hemolysins secreted by Photorhabdus probably become inactive fairly quickly. The
hemolysins in the filter-sterilized supernatant must completely degrade before the assay
is complete. In contrast, the PBS-washed cells continue to secrete hemolysin during the
assay, but the overall concentration is less than in the original culture medium containing
bacterial cells. Additionally, the presence of a cell-associated co-factor may be required
for the activity of secreted hemolysins. This may explain why the cells plus culture
sample appears to have a synergistic hemolytic effect compared to the cell-only sample.
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HEMOLYSIS MAY NOT BE REQUIRED FOR FULL VIRULENCE

My initial hypothesis was that the hemolytic activity observed in Photorhabdus
assisted the bacteria during insect infectivity. Several studies on Xenorhabdus indicate a
possible role of hemolysins in immunoevasion (Brillard et al., 2001; Cowles and
Goodrich-Blair, 2005). However, the data from this study imply this may not be the case
for Photorhabdus. Most of the hemolysis mutants were not altered in virulence; in fact,
only 10 of the 74 hemolysis mutants were confirmed to have delayed pathogenesis. This
finding indicates that hemolysis does not play a significant role in pathogenesis. The few
mutants that were altered in both hemolysis and pathogenesis are most likely the result of
disruptions in global regulatory elements, rather than a correlation between hemolytic
activity and virulence. This notion is supported by the genes that were identified for
several mutants, described in the following sections.

REGULATION OF HEMOLYSIS AND VIRULENCE IN PHOTORHABDUS

As previously stated, the majority of the genes identified in this study were
regulatory or transport-related. The lipopolysaccharide heptosyltransferase I protein,
identified in defective hemolysis/delayed virulence mutant 53 H3, is responsible for
attaching the first heptose molecule to Kdo during LPS inner-core synthesis (Grizot et al.,
2006). Interestingly, the absence of this heptose is known to cause attenuated virulence in
Gram negative bacteria. This coincides with my finding of delayed pathogenesis for this
mutant. Incomplete formation of LPS likely also inhibits the adequate secretion of
hemolysin, thus resulting in the defective hemolysis of this mutant. Another translocating
protein, phosphoserine aminotransferase (PSAT), was identified in early hemolysis
mutant 86 C7. PSAT catalyzes the second step of the phosphorylated serine biosynthesis
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pathway (Mishra et al., 2010). This enzyme has also been shown to be involved in
alanine synthesis (Kim et al., 2010). 86 C7 is affected in almost every phenotype,
including a decrease in growth rate, which is not surprising given the likely auxotrophy
of this mutant. The disruption in the synthesis of these amino acids likely affects many
other intermediates and pathways involved in homeostasis.
The delayed hemolysis/delayed pathogenesis mutant 30 F2 identified a transposon
insertion site within a gene encoding a hypothetical protein of unknown function.
However, this gene is immediately upstream of the gene encoding UDP-glucose 4epimerase, the enzyme that catalyzes the stereochemical conversion of UDP-glucose to
UDP-galactose (Mori et al., 2008). Many virulence factors are synthesized using UDPgalactose, therefore it would makes sense that this mutant has a delay in pathogenesis if
the transposon is affecting transcription of this downstream gene. This is a likely
explanation, but QRT-PCR would be needed to determine to what extent the transposon
is affecting this gene, if at all.
The defective hemolysis mutant 41 B3 had a disruption in the ATP-dependent
protease HslV. HslV is a heat shock protein that functions as the proteolytic subunit of
the two-component ATP-dependent protease HslVU (Lee et al., 2009). This complex is
important in regulatory protein turnover; in this way, inactivation of HslV is probably
inhibiting the turnover of hemolysin repressor proteins. Without the inhibition of these
repressors, hemolysin activity would continue to be suppressed.
The last two unique mutants, 46 G6 and 71 H4, had transposon insertions in genes
that cannot be clearly related to the observed phenotypes. 46 G6 identified a transposase
sequence; this transposase actually has seven identical paralogs in the P. temperata
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genome. Sequencing from the opposite end of the transposon was able to determine
which paralog actually contained the insertion. This transposase is located next to the
secreted protein Hep (hemolysin coregulated protein), which is part of the Type VI
secretion system. However, end point RT-PCR determined that this Hep gene was still
producing transcript, which discredits the possibility that the observed phenotypes were
due to disruptions with Hep expression. The disruption in 71 H4 is equally puzzling; this
gene has similarities with the lambda phage repressor protein CI, which is involved in the
switch between the lysogenic and lytic growth phases (Galkin et al., 2009). This repressor
self-cleaves under the SOS response. The most likely explanation is that the proteins
coded by these two genes act as regulators to biological intermediates of other pathways
that are indirectly related to the expression of hemolysis and virulence.

MEMBRANE FUSION PROTEIN PRTC IS INVOLVED IN HEMOLYSIS

Two defective hemolysis mutants, 22 A2 and 90 E2, had insertions within the same
gene, prtC. The insertion sites for these mutants are located 1110 bp apart; therefore,
these mutants are not siblings but rather arose independently from one another.
Phenotypically, these mutants are indistinguishable; both express primary wild type
characteristics with the exception of protease secretion, for which they are defective. This
observation is not surprising given that prtC belongs to the prtBCD protease ABC
transporter locus (Bowen et al., 2003). PrtC is a membrane-fusion protein (MFP) and is
involved in the secretion of the RTX-like metalloprotease PrtA. Although once suspected
to be a major virulence factor in Photorhabdus, PrtA actually is involved in the
bioconversion of host tissues during late infection. For this reason it is not surprising that
22 A2 and 90 E2 retained wild type virulence while losing protease activity.
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Interestingly, NCBI's BLAST program identified sequence similarities with a gene
encoding HlyD in Serratia odorifera. HlyD is a type I secretion membrane fusion protein
involved in the extracellular transport of hemolysin (Pimenta et al., 2005). In E. coli, this
protein spans the periplasm and is responsible for the direct extracellular transport of
Hemolysin A (HlyA). Members of the MFP family share structural domain similarities
and transport a variety of compounds out of the cell. This suggests the possibility that the
PrtC protein of Photorhabdus may share involvement in the transport of hemolysin.
Disruption of prtC may have caused an absence of expression or a structural misfolding
of the protein, which would inhibit the exportation of protease and possibly hemolysin as
well.

DISCREPANCIES IN PLEIOTROPIC EFFECTS OF IDENTICAL MUTANTS 50 C5 AND 51F9

Sequencing of two defective hemolysis mutants, 50 C5 and 51 F9, identified
transposon insertion sites at the same positions within pte2343, a gene encoding a
conserved hypothetical protein. Phenotypic characterization revealed that these two
mutants are physiologically identical, exhibiting primary phase wild type characteristics;
however, 50 C5 is a confirmed pathogenesis mutant, while 51 F9 is not. Initial virulence
screening of 51 F9 identified an LT50 and LTioo of >57 h and >65 h, respectively. Both
times were delayed by 10 h when compared to the primary parental wild type. However,
the MOI assay did not confirm this delay in pathogenesis at the four cell dosages tested.
Genetically, these two mutants are identical; therefore, all phenotypes should be identical
as well. There are a few possible explanations as to why only one of these mutants
consistently exhibits delayed pathogenesis.
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One such explanation for this discrepancy in virulence may be attributable to the
complexity of using a live multicellular organism. Although the in vitro killing assay
using Galleria mellonella is an effective means of testing virulence levels (Waterfield et
al., 2009), it can also be quite variable due to a number of factors. Some of the difficulties
associated with using a live multicellular model are the extreme sensitivity of the larvae
to hot and cold temperatures. Also, larval age, feed, conditions during shipment, as well
as the overall health of a particular batch of larvae upon arrival all contribute to
variability in the testing process. The use of controls helps to ameliorate some of these
fluctuations, but inconsistencies between data sets are still possible. The MOI assay for
50 C5 may have been tested on a slightly stronger batch of larvae, resulting in a more
noticeable delay in pathogenesis compared to 51 F9. Testing these two mutants within the
same batch of larvae may resolve this discrepancy.
Another possible explanation for the discrepancy could be that 51 F9 may have a
double insertion. Southern analysis was only performed on 50 C5, which showed that this
mutant contains only one transposon insertion. 51 F9 has not been analyzed by Southern
blot, so a possibility remains that this mutant may have multiple transposon insertions.
This option could explain the pathogenic incongruity between these two seemingly
identical mutants. Southern analysis would need to be performed to rule out this
possibility.

REGULATORY EFFECTS OF THE CARBAMOYL-PHOSPHATE SYNTHASE LARGE CHAIN

A second group of hemolysis mutants had transposon insertion sites within the same
gene. 30 C6, 32 E4, and 41 D5 were all delayed for hemolysis and had disruptions in
carB, the gene encoding the large subunit of the carbamoyl-phosphate synthetase (CPS)
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holoenzyme. CPS is a heterodimer involved in pyrimidine biosynthesis (Lund et al.,
2010). The large subunit specifically catalyzes carbamoyl phosphate formation, while the
small subunit hydrolyzes glutamine. Carbamoyl phosphate subsequently functions in
arginine and pyrimidine nucleotide synthesis (Holden et al., 1999).
30 C6, 32 E4, and 41 D5 display primary wild type characteristics with the
exception of siderophore production. These three mutants were unable to grow on CAS
agar. This is not surprising given that CAS is a minimal-nutrient medium. Interference
with pyrimidine synthesis could easily hinder the production of arginine or other organic
compounds required for growth. The resulting auxotrophy would explain why these
mutants do not grow on CAS.
Although a definitive role of CPS in hemolysin expression is not immediately
clear, it is likely that this disruption causes an incomplete product formation that is in
some way involved in the regulation of hemolysis. For instance, irregular protein folding
or the absence of a crucial regulatory intermediate could explain the delay in hemolysis
initiation. If a particular repressor for hemolysis was malformed in its inducer binding
site, then the repressor would continue to interfere with hemolysin expression. Another
possibility could be the absence of an activator required to initiate hemolysin expression.
Both of these scenarios would cause a lack of hemolysis until the activity of additional
hemolysins, under other forms of regulatory control, were able to compensate for the
inactive hemolysin. This could explain why hemolysis is not observed until at least 48 h
growth.
One other peculiar observation surrounds these CPS mutants, and that is that 30
C6 is also delayed for pathogenesis, while 32 E4 and 41 D5 are not. 32 E4 and 41 D5
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were both putative pathogenesis mutants during initial screening, but were not confirmed
at the four dosages injected during the MOI assays. As explained before with 50 C5 and
51 F9, it is possible that variability in insect health during testing biased the confirmation
of only 30 C6 as delayed pathogenesis. However, unlike 50 C5 and 51 F9, these three
mutants all have different insertion sites. The insertion site of 30 C6 is the closest to the
beginning of the gene; therefore, it is possible that 32 E4 and 41 D5 have enough
sequence transcribed to translate into a partially functional protein, whereas the gene
function in 30 C6 could be entirely knocked out.

10A Cll AND 10A H12 ARE IDENTICAL EXORIBONUCLEASE II MUTANTS

Molecular analysis of the pathogenesis mutants 10A Cll and 10A H12 revealed
mutations in the rnb gene which encodes Exoribonuclease II (RNase II). These two
mutants are identical; the transposon insertion site within the disrupted gene is the same
in both mutants. This finding indicates that these two mutants arose from a single
transformed cell; therefore, 10A Cll and 10A H12 are indistinguishable, both genetically
and phenotypically. Interestingly, the RNase II gene found in this mutant pair was also
found previously in a pathogenesis mutant, UNH 1307 (Rowedder, 2009). Similar to
UNH 1307, 10A Cll and 10A H12 are completely defective for motility, hemolysis, and
dye binding on MacConkey and EMB. 10A Cll and 10A H12 are also negative for
lipase, although UNH 1307 was not tested. These three mutants are not identical,
however. UNH 1307 is completely defective for protease, antimicrobial activity, and
calcofluor binding. 10A Cll and 10A HI2 bind calcofluor, and are positive, albeit
significantly reduced (<1 mm), for protease and antimicrobial activity. Although the
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precise insertion site of UNH 1307 is unknown, it can be speculated that this mutant is not
an identical clone of the other two.
RNase II is a 3' to 5' exoribonuclease and is a key player in RNA maturation and
turnover, as well as mRNA decay (Zuo et al., 2006; Domingues et al., 2009). The
structure of RNase II is comprised of two cold shock domains, one catalytic domain, and
one substrate-binding domain (Zuo et al., 2006; Arraiano et al., 2010). This complex
hydrolyzes single-stranded RNA by excising mononucleotides from the 3' end, leaving a
short oligonucleotide. Enzyme expression and activity is controlled at both the
transcriptional and post-transcriptional levels (Domingues et al., 2009) and is also
dependent on environmental conditions. For this reason, RNase II may be involved in the
stress response of pathogens during infection.

79 B5 IS AN RNA PYROPHOSPHOHYDROLASE ( R P P H ) MUTANT

Molecular analysis of 79 B5, a defective hemolysis/delayed pathogenesis mutant,
identified a disruption in nudH, a gene encoding adenosine (5')-pentaphospho-(5")adenosine pyrophosphohydrolase. This protein is actually an RNA pyrophosphohydrolase
(RppH), which is a member of the Nudix hydrolase superfamily. Proteins belonging to
the Nudix family have a wide range of functions but are all characterized by their ability
to hydrolyze substrates containing a nucleoside diphosphate attached to a functional
group, X (McLennan, 2006). The general purpose of these proteins is cellular
housecleaning and homeostasis by degrading extraneous metabolites and biochemical
intermediates. RppH is one particular Nudix protein involved in the initiation of mRNA
degradation. RppH cleaves the 5' end of triphosphorylated mRNA to generate a
monophosphorylated RNA which in turn is more susceptible to the endonucleolytic
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activity of RNase E (Deana et al., 2008). In this way, RppH is thought to be involved in
initiating the rapid turnover of transcript in prokaryotes.

MULTIPLE RNASES MAY BE INVOLVED IN THE REGULATION OF PATHOGENESIS

Genetic analysis of mutants altered in pathogenesis identified two different
RNases in Photorhabdus: RNase II and RppH. Although the RNase II mutants (10A CI 1,
10A HI2, and UNH 1307) and the RppH mutant (79 B5) are not phenotypically identical
to one another, it is likely that the cause of the absence of hemolysis and delay in
pathogenesis are the same.
RNase II degrades mRNA by hydrolyzing nucleotides from the 3' end of ssRNA.
RppH cleaves phosphates from the 5' end of triphosphorylated mRNA, thus marking the
message for subsequent degradation by RNase E. Although these mechanisms are slightly
different, the end result is the same: mRNA decay. It is likely that, in both cases, the
mRNA being degraded encodes repressors of global regulators that ultimately control the
expression of hemolysis and virulence factors. If the activity of either RNase II or RppH
is knocked out, then the message from which these repressors are translated will not be
degraded. This would result in overexpression of the repressors; the global regulators
would continue to be suppressed. This suppression could inhibit the production of
hemolysins and critical virulence factors, in addition to any other genes under the control
of that regulator.
Traditionally, RNA was believed to function only as transcript or to carry out
translation. We are just now beginning to fully understand the importance of RNases and
non-coding RNAs in the genetic regulation of prokaryotes. Transcriptional activation and
repression can be controlled by non-coding RNA, especially under conditions of stress
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(Boots and Moll, 2009). Recent studies also show a definite role of RNases in
pathogenesis. Non-coding RNAs have also been shown to regulate the RNA chaperone
Hfq, which is involved in virulence (Boots and Moll, 2009). Erova et al. (2008) showed
that the exoribonuclease RNase R is a cold shock protein involved in the pathogenesis of
Aeromonas hydrophila. Complementation confirmed that RNase R is encoded by the
virulence-associated gene vacB. Complementation of UNH1307 also showed a
restoration of wild type virulence (Rowedder, 2009). To verify the role of RNase II and
RppH in causing the observed hemolysis and pathogenesis phenotypes in my mutants,
complementation will need to be performed.

SIGNIFICANCE

During this study I screened the 10,000-transposant library for hemolysis and
identified 74 displaying defective, delayed, or early hemolysis. Subsequent pathogenesis
testing confirmed that 10 of these mutants are also delayed for pathogenesis. This finding
does not provide evidence for the direct involvement of hemolysins in insect infectivity
by Photorhabdus; however, these mutants do provide novel insight into the genes
involved in the regulation of both hemolysis and virulence. Genetic characterization of 16
mutants identified a diverse array of regulatory and transport proteins that are involved in
the control of hemolysis, and in some cases virulence, in Photorhabdus. One of the most
important findings from this study is the further support for the regulatory role of RNases
and non-coding RNAs in Photorhabdus.
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FUTURE DIRECTIONS

The primary focus of this study was to investigate the potential relationship between
hemolysis and virulence. This aim was achieved mainly by looking at mutants defective
in both characteristics, which excluded the 11 identified early hemolysis mutants. These
mutants, however, display some unique characteristics that are worth looking into.
Interestingly, although the 11 early hemolysis mutants initiate hemolysis before the
primary, these mutants do not appear to have an increased level of hemolytic activity.
Although the plate assay method is not quantitative, the early mutants all had zones of
hemolysis that were several mm smaller than the primary parental wild type, despite
showing early signs of hemolysis. A liquid assay is necessary to confirm the potential
decreased level of hemolysis. This group of mutants could be a very interesting collection
to study for mechanisms of transport and regulation, as there appears to be an inverse
relationship between the time of hemolysis initiation and the overall level of blood lysing
activity. Additionally, a more in depth look at the virulence of these mutants may reveal
interesting data. Preliminary screening of hemolysis mutants for pathogenesis defects was
primarily focused on the identification of mutants with decreased virulence. Initial
screening of the early hemolysis mutants did not identify mutants with enhanced
virulence, but a closer look at this group may reveal mutants with enhanced pathogenesis
that were previously missed given the focus of this study. An in-depth characterization of
this group of mutants would be an interesting and advisable project for an undergraduate.
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